リウマチ病セミナー Ｖ

電子書籍
章別単位で購入
ブラウザ、アプリ閲覧

4,400 円(税込)

購入する

商品紹介

昨今のリウマチ病研究の興味が、ウイルス感染、免疫、遺伝子、サイトカインの阻害薬などに向けられている反面、現場の医師には各関節の生病理、症状、治療についての豊富な知識も要求される。こういう観点から、肩関節、肋椎、肋横突関節、近位脛腓関節、足関節のリウマチ症状や高齢者後弯の病態といったテーマも選ばさせてもらった。その他、fibroblastic rheumatism　をとりあげた。また、チオプロニンおよびブシラミンのこれまでの知見を、D-ペニシラミンとともに、紹介してもらうことにした。（序文より）

目次

  • 表紙
  • 執筆者一覧
  • 序文
  • 目次
  • 炎症リウマチ
  • ヒトパルボウイルスB19(HPV/B19)のリウマチ症状
  • シェーグレン症候群1993
  • Multicentric reticulohistiocytosis
  • 肝炎ウイルスとリウマチ病
  • Raynaud現象
  • RAの予後
  • Fibroblastic rheumatism(線維芽細胞性リウマチ)とリウマチ病でのfibrosis
  • 骨関節, 脊椎, 神経
  • Fibromyalgiaのレゾンデートル
  • 関節鏡視下肩峯下除圧術
  • 肋椎および肋横突関節の病理とリウマチ症状
  • 不安定足関節
  • 高齢者後弯の病態
  • 近位脛腓関節の臨床症状
  • RA頸椎managementの争点
  • Keegan型頸椎症
  • 検査法
  • 関節液の細胞診断
  • リウマトイド因子の臨床的意義
  • Dual energy x-ray absorptiometry(DEXA)による局部osteoporosisの測定
  • 生物学的反応
  • ホスホリパーゼA2と炎症
  • Antiphospholipid antibodyの最近の知見
  • 痛みとproto-oncogeneの発現
  • NK cellとリウマチ病
  • Superantigenと自己免疫疾患
  • 治療と副作用
  • リウマチ治療におけるD-ペニシラミンとチオプロニンおよびブシラミン
  • 抗リウマチ薬の選択
  • Cytotoxic-agentsに対する多剤抵抗性
  • 炎症性サイトカインの阻害薬
  • 抗関節症薬
  • リウマチ病における遺伝子治療
  • 手術
  • 人工関節のゆるみとリウマトイド肉芽
  • 脊椎悪性腫瘍の手術
  • 索引(リウマチ病セミナー1～V)
  • DRUG INFORMATION
  • 奥付

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

炎症リウマチ

P.8 掲載の参考文献
1) Ozawa K, Kurtzman G, Young N:Productive infection by B19 parvovirus of human erythroid bone marrow cells in vitro. Blood 70:384-391, 1987
PubMed
2) Ozawa K, Kurtzman G, Young N:Replication of the B19 parvovirus in human bone marrow cell cultures. Science 233:883-886, 1986
PubMed
3) Takahashi T, Ozawa K, Takahashi K, et al:Susceptibility of human erythropoietic cells to B19 parvovirus in vitro increases with differentiation. Blood 75:603-610, 1988
 
4) Ozawa K, Young N:Characterization of capsid and noncapsid proteins of B19 parvovirus propagated in human erythroid bone marrow cultures. J Virol 61:2627-2630, 1987
PubMed
5) Ozawa K, Ayub J, Young N:Functinal mapping of genome of the B19 (human) parvovirus by in vitro translation after negative hybrid selection. J Virol 62:2508-2511, 1988
 
6) Ozawa K, Ayub J, Kajigaya S, et al:The gene encoding the nonstructural protein of B19 (human) parvovirus may be lethal in transfected cells. J Virol 62:2884-2889, 1988
 
7) Cossart YE, Field AM, Cant B, et al:Parvovirus-like particles in human sera. Lancet I:72-73, 1975
PubMed
8) Pattison JR, Jones SE, Hodgson J, et al:Parvovirus infection and hypoplastic crises in sickle cell anaemia. Lancet 1:664-665, 1981
 
9) Anderson MJ, Jones SE, Fisher-Hoch SP, et al:Human parvovirus:the cause of erythema infectiosum (fifth disease) ? Lancet 1:1378, 1983
 
10) Brown T, Anand A, Ritchie LD, et al:Intrauterine parvovirus infection and hydrops fetalis. Lancet 2:1033-1034, 1984
PubMed
11) Woolf AD, Campion GV, Chishick A, et al:Clinical manifestations of human parvovirus B19 in adults. Arch Intern Med 149:1153-1156, 1989
PubMed
12) Anderson MJ, Higgins PG, Davis LR, et al:Experimental parvovirus infection in human. J Infect Dis 152:257-265, 1985
 
13) Potter CG, Potter AC, Hatton CSR, et al:Variation of erythroid and myeloid precursors in the marrow and peripheral blood of volunteer subjects infected with human parvovirus (B19). JCIin Invest 79:1486-1492, 1987
 
14) Simpson RW, Smith CA, Godzeski CW, et al:Association of parvovirus with rheumatoid arthritis of humans. Science 244:1425, 1984
 
15) Reid DM, Reid TMS, Brown T, et al:Human parvovirus-associaed arthritis:a clinical and laboratory description. Lancet 1:422-425, 1985
 
16) Kurtzman GJ, Ozawa K, Cohen B, et al:Chronic bone marrow failure due to persistent B19 infection. N Engl J Med 317:287-294, 1987
PubMed
17) Weiland HT, Salimans MMM, Fibbe WE, et al:Prolonged parvovirus B19 infection as a cause of severe anaemia in a bone marrow transplant recipient. Br J Haematol 71:330, 1989
 
18) Graeve JLA, de Alarcon PA, Naides SJ:Parvovirus B19 infection in patients receiving cancer chemotherapy:the expanding spectrum of disease. Am J Pediatr Hematol Oncol 11:441-444, 1989
 
19) Frickhofen N, Abkowitz JL, Safford M, et al:Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1(HIV-1):a treatable cause of anemia in AIDS. Ann Intern Med 113:926-933, 1990.
PubMed
20) Mortimer PP:Transmission of serum parvovirus-like virus by clotting-factor concentrates. Lancet 2:482-484, 1983
PubMed
21) Foto F, Saag KG, Scharosch LL, et al:Parvovirus B19-specific DNA in bone marrow from B19 arthropathy patients:evidence for B19 virus persistence. J Infec Dis 167:744-748, 1993
 
22) Saal JG, Steidle M, Einsele H, et al:Persistence of B19 parvovirus in synovial membranes of patients with rheumatoid arthritis. Rheumatol 12:147-151, 1992
PubMed
P.18 掲載の参考文献
1) Wollheim FA:Henrik Sjogren and Sjogren's syndrome. Scand J Rheumatol 61:11-16, 1986
 
2) Whaley K, Alspaugh MA:Sjogren's syndrome. In Textbook of Rheumatology, 3rd ed. (Ed. Kelly WN, Harris ED, Ruddy S, Sledge CB), pp. 999-1091, Philadelphia, WB Saunders, 1989
 
3) Jacobsson LTH, Axell TE, Hansen BU, et al:Dry eyes and mouth:an epidemiological study in Swedish adults, with special reference to primary Sjogren's syndrome. J Autoimmun 2:521-527, 1989
 
4) Vitali C, Bombardieri S, Moutsopoulos HM, et al:Preliminary criteria for the classification of Sjogren's syndrome. Results of a prospective concerted action supported by the European community. Arthritis Rheum 36:340-347, 1993
PubMed
5) Kosuda S, Suzuki K, Kawakami R, et al:Reassessment of usefulness of salivary scintigraphy in diagnosis of Sjogren's syndrome. Kaku Igaku 30:161-170, 1993
PubMed
6) 大藤 眞:シェーグレン症候群診断基準. 厚生省特定疾患シェーグレン病調査研究班 昭和52年度研究業績, p. 6, 1979
 
7) Jacobsson LTH, Hansen BU, Manthorpe R, et al:Association of dry eyes and dry mouth with anti-Ro/SS-A and anti-La/SS-B autoantibodies in normal adults. Arthritis Rheum 35:1492-1501, 1992
 
8) Tsuzaka K, Ogasawara T, Tojo T, et al:Relationship between autoantibodies and clinical parameters in Sjogren's syndrome. Scand J Rheumatol 22:1-9, 1993
PubMed
9) Reveille JD, Arnett FC:The immunogenetics of Sjogren's syndrome. Reumatic Disease Clinics of North America 18:539-550, 1992
 
10) Markusse HM, Otten HG, Vroom TM, et al:Rheumatoid factor isotypes in serum and salivary fluid of patients with primary Sjogren' s syndrome. Clin Immunol Immunopathol 66:26-32, 1993
PubMed
11) van der Geest SA, Markusse HM, Swaak AJ:Beta 2 microglobulin measurements in saliva of patients with primary Sjogren's syndrome:influence of flow. Ann Rheum Dis 52:461-463, 1993
PubMed
12) Markusse HM, Otten HG, Vroom TM, et al:The diagnostic value of salivary fluid levels of beta 2 microglobulin, lysozyme and lactoferrin for primary Sjogren's syndrome. Clin Rheumatol 11:521-525, 1992
PubMed
13) Adamson TC, Fox RI, Frisman DM, et al:Immunohistologic analysis of lymphoid infiltrates in primary Sjogren's syndrome using monoclonal antibodies. J Immunol 130:203-208, 1983
PubMed
14) Saito I, Terauchi K, Shimuta M, et al:Expression of cell adhesion molecules in the salivary and lacrimal glands of Sjogren's syndrome. J Clin Lab Anal 7:180-187, 1993
PubMed
15) Thrane PS, Halstensen TS, Haanaes HR, et al:Increased epithelial:expression of HLA-DQ and HLA-DP molecules in salivary glands from patients with Sjogren's syndrome compared with obstructive sialadenitis. Clin Exp Immunol 92:256-262, 1993
 
16) Foster H, Stephenson A, Walker D, et al:Linkage studies of HLA and primary Sjogren's syndrome in multicase families. Arthritis Rheum 36:473-484, 1993
 
17) Pease CT, Charles PJ, Shattles W, et al:Serological and immunogenetic markers of extraglandular primary Sjogren's syndrome. Br J Rheumatol 32:574-577, 1993
PubMed
18) Moriuchi J, Ichikaw Y, Takaya M, et al:Association HLA and Sjogren's syndrome in Japanese patients. Arthritis Rheum 29:1518-1521, 1986
 
19) Miyagawa S, Dohi K, Shima H, et al:Absence of HLA-B 8 and HLA-DR 3 in Japanese patients with Sjogren's syndrome positive for anti-SSA (Ro). J Rheumatol 19:1922-1924, 1992
 
20) Zumla A, et al:T cell receptor expression in Sjogren's syndrome. Ann Rheum Dis 50:691-693, 1991
PubMed
21) Sumida T, Yonaha F, Maeda T, et al:T cell receptor repertoire of infiltrating T cells in lips of Sjogren's syndrome patients. J CIin Invest 89:681-685, 1992
 
22) Dwyer E, Itescu S, Winchester R:Characterization of the primary structure of T cell receptor beta chains in cells infiltrating the salivary gland in the sicca syndrome of HIV-1 infection. Evidence of antigen-driven clonal selection suggested by restricted combinations of V beta J beta gene segment usage and shared somatically encoded amino acid residues. J Clin Invest 92:495-502, 1993
 
23) Calabrese LH, Wilke WS, Perkins AD, et al:Rheumatoid arthritis complicated by infection with the human immunodeficiency virus and the development of Sjogren'ssyndrome. Arthritis Rheum 32:1453-1457, 1989
 
24) Miyoshi I, Kubonishi I, Yoshimoto S:Type C virus particles in a cord T-cell line derived by co-cultivating normal human cord leukocytes and human leukaemic T cells. Nature 294:770-771, 1981
 
25) Eguchi K, Matsuoka N, Ida H, et al:Primary Sjogren's syndrome with antibodies to HTLV-1:clinical and laboratory features. Ann Rheum Dis 51:769-776, 1992
PubMed
26) Green JE, Hinrichs SH, Vogel J, et al:Exocrinopathy resembling Sjogren's syndrome in HTLV:I tax transgenic mice. Nature 341:72-74. 1989
PubMed
27) Mariette X, Agbalika F, Daniel MT, et al:Detection of human T lymphotropic virus type I tax gene in salivary gland epithelium from twe patients with Sjogren's syndrome. Arthritis Rheum 36:1423-1428, 1993
 
28) Matsumoto Y, Muramatsu MO, Sato K:Mixed connective disease and Sjogren's syndrome accompanied by HTLV-1 infection. Intern Med 32:261-264, 1993
 
29) DeClerck LS, Couttenye MM, deBroe ME, et al:Acquired immunodeficiency syndrome mimicking Sjogren's syndrome and systemic lupus erythematosus. Arthritis Rheum 31:272-275, 1988
 
30) Talal N, Dauphinee MJ, Dang H, et al:Detection of serum antibodies to retroviral proteins in patients with primary Sjogren's syndrome (autoimmune exocrinopathy). Arthritis Rheum 33:774-781, 1990
PubMed
31) Yeh CK, Fox PC, Goto Y, et al:Human immunodeficiency virus (HIV) and HIV infected cells in saliva and salivary glands of a patient with systemic lupus erythematosus. J Rheumatol 19:1810-1812, 1992
 
32) Itescu S, Brancato LJ, Buxbaum J, et al:A diffuse infiltrative CD 8 lymphocytosis syndrome in human immunodeficiency virus (HIV) infection:a host immune response associated with HLA-DR 5. Ann Inter Med 112:103-107, 1990
 
33) Coll J, Tomas S, Corominas JM, et al:Sicca syndrome associated with human immunodeficiency virus infection:an immunohistological study. Arthritis Rheum 36:875-876, 1993
 
34) Garry RF:Extensive antigenic mimicry by retrovirus capsid proteins. Aids Research and Human Retroviruses 6:1361-1362, 1990
PubMed
35) Haddad J, et al:Lymphocytic sialadenitis of Sjogren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 339:321-323, 1992
 
36) Komiyama K, et al:HCV in saliva of chronic hepatitis patients having dental treatment. Lancet 338:572-573, 1991
PubMed
37) Mariette X, Zerbib M, Jaccard A, et al:Hepatitis C virus and Sjogren's syndrome. Arthritis Rheum 36:280-281, 1993
PubMed
38) Whittingham S, et al:Primary Sjogren's syndrome after infectious mononucleosis. Ann Intern Med 102:490-495, 1985
PubMed
39) Taneichi K, Nagashima M, Shibaki H:A patient with rheumatoid arthritis complicated by Sjogren's syndrome that was possibly caused by reactivation of Epstein-Barr virus. Intern Med 32:77-79, 1993
PubMed
40) Mariette X, Gozlan J, Clerc D, et al:Detection of Epstein-Barr virus DNA by in site hybridization and polymerase chain reaction in salivary gland biopsy specimens from patients with Sjogren's syndrome. Arn J Med 90:286-294, 1991
 
41) Saito I, Servenius B, Compton T, et al:Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjogren's syndrome. J Exp Med 169:2191-2198, 1989
PubMed
42) Tateishi M, Saito I, Yamamoto K, et al:Spontaneous production of Epstein-Barr virus by B lymphoblastoid cell lines obtained from patients with Sjogren's syndrome. Arthritis Rheum 36:827-835, 1993
 
43) Sixbey JW, Yao QY:Immunoglobulin A-induced shift of Epstein-Barr virus tissue tropism. Science 255:1578, 1992
PubMed
44) Fox RI, Hogli TE, Lanier LL, et al:Salivary gland lymphocytes in primary Sjogren's syndrome lack lymphocytes subsets defined by Leu-7and Leu-11 antigens. J Immunol 135:207-214, 1985
 
45) Shiozawa S, Shiozawa K, Shimizu S, et al:Immunoreactive circulating alpha-interferon is low in Sjogren's syndrome. Br J Rheumatol 29:50-52, 1990
PubMed
46) Minato N, Takeda A, Kano S, et al:Studies on the functions of natural killer-interferon system in patients with Sjogren's syndrome. J Clin Invest 69:581-588, 1982
PubMed
47) Miyasaka N, Seaman W, Bakshi A, et al:Natural killing activity in Sjogren's syndrome. An analysis of defective mechanisms. Arthritis Rheum 26:954-960, 1983
PubMed
48) Shiozawa S, Morimoto I, Tanaka Y, et al:A preliminary study on the interferon-α treatment for xerostomia of Sjogren's syndrome. Br J Rheumatol 32:52-54, 1993
 
P.28 掲載の参考文献
1) Barrow MV, Holubar K:Multicentric reticulohistiocyotosis:a review of 33 patients. Medicine 48:287-305, 1969
PubMed
2) Campbell DA, Edwards NL:Multicentric reticulohistiocytosis:systemic macrophage disorder. Bailliere Clin Rheumatol 5:301-319, 1991
 
3) 山田耕次, 鷲崎久美子, 富沢尊儀ら:Multicentric reticulohistiocytosisの1例. 皮膚臨床34:291-295, 1992
 
4) Rene J, Starz T, Miller EB, et al:Multicentric reticulohistiocytosis and Sjogren's syndrome. Arthritis Rheum 33:870-1871, 1990
 
5) Kuwabara H, Uda H, Tanaka S:Multicentric reticulohistiocytosis:report of a case with electron microscopic studies. Acta Pathol Jpn 42:130-135, 1992
PubMed
6) 馬場直子, 宮本秀明, 長谷哲男ら:Multicentric reticulohistiocytosisの1例. 臨皮42:947-950, 1988
 
7) Nunnick JC, Krusinski PA, Yates JW:Multicentric reticulohistiocytosis and cancer:acase report and review of the literature. Med Pediatr Oncol 13:273-279, 1985
 
8) Nakajima Y, Sato K, Morita H, et al:Severe progressive erosive arthritis in multicentric reticulohistiocytosis:possible involvement of cytokines in synovial proliferation. J Rheumatol 19:1643-1646, 1992
 
9) 中村憲正, 政田和洋, 越智隆弘ら:Methotrexateが著効を奏した Multicentric reticulohistiocytosisの1例. 臨整外25:651-655, 1990
 
10) Ginsburg WW, O'Duffy JD, Morris JL, et al:Multicentric reticulohistiocytosis:response to alkylating agents in six patients. Ann Intern Med 111:384-388, 1989
PubMed
P.38 掲載の参考文献
1) Amor B, Dougados M, Mijiyama M:Critbres de classification des spondylarthropathies. Rev Rhum 57:85-89, 1990
 
2) Duffy J, Lidsky MD, Sharp JT, et al:Polyarthritis, polyarteritis and hepatitis B. Medicine 55:19-37, 1976
 
3) Ytterberg SR:Viral arthritis. In Arthritis and Allied Conditions (Ed, McCarty DJ and Koopman WJ), pp. 2047-2065, Philadelphia, Lea and Febiger, 1993
 
4) Duffy J:Arthritis and liver disease. In Arthritis and allied conditions (Ed, McCarty DJ and Koopman WJ), pp. 1111-1120, Philadelphia, Lea and Febiger, 1993
 
5) Bridgeford PH, Lowenstein M, Bocanegra TS, et al:Polymyalgia rheumatica and giant cell arteritis; histocompatibility typing and hepatitis-B infection studies. Arthritis Rheum 23:516-518, 1980
PubMed
6) Rogerson SJ, Nye FJ:Hepatitis B vaccine associated with erythema nodosum and polyarthritis. BMJ 301:345, 1990
PubMed
7) Combes B, Stastny P, Shorey J, et al:Glomerulonephritis with deposition of Australia antigen-antibody complexes in glomerular basement membrane. Lancet II 234-237, 1971
 
8) Takekoshi Y, Tanaka M, Miyakawa Y, et al:Free "small" and IgG-associated "large" hepatitis Be antigen in the serum and glomerular capillary walls of two patients with membranous glomerulonephritis. N Eng J Med 300:814-819, 1979
 
9)Iman RD, Hodge M, Johnson MEA, et al:Arthritis, vasculitis, and cryoglobulinemia associated with relapsing hepatitis A virus infection. Ann Intern Med 105:700-703, 1986
 
10) Ueno Y, Kinoshita R, Kishimoto I, et al:Polyarthritis associated with hepatitis C virus infection. Brit J Rheum 33:289-291, 1994
 
11) Galli M, Monti G, Monteverde A, et al:Hepatitis C virus and mixed cryoglobulinemias. Lancet 339:989, 1992
PubMed
12) Haddad J, Deny P, Munz-Gotheil C, et al:Lymphocytic sialadenitis of Sjogren's syndrome associated with chronic hepatitis C virus liver disease. Lancet 339:321-323, 1992
PubMed
13) Almasio P, Provenzano G, Scimemi M, et al:Hepatitisc virus and Sjogren's syndrome. Lancet 339:989-990, 1992
 
14) Cacoub P, Lunel-Fabiani F, Huong LT, et al:Polyarthritis nodosa and hepatitis C virus infection. Ann Inter Med 116:605-606, 1992
 
15) Sawada T, Hirohata S, Inoue T, et al:Development of rheumatoid arthritis after hepatitis C virus infection. Arthritis Rheum 34:1620-1621, 1991
PubMed
16) Hirohata S, Inoue T, Ito K:Hepatitis C virus infection and rheumatoid arthritis:differential expression of anti-c-3 and anti-GOR antbodies. J Rheumatol 20:204-205, 1993
 
17) Hirohata S, Inoue T, Ito K, et al:Rheumatoid arthritis associated with hepatitis C virus infection:the presence of viral RNA in leukocytes and its relevence with the genetic susceptibility. Arthritis Rheum 36:s 267, 1993
 
18) Mariette X, Zerbib M, Jaccard A, et al:Hepatitis C virus and Sjogren's syndrome. Arthritis Rheum 36:280-281, 1993
PubMed
19) Agnello V, Chung RT, Kaplan LM:A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 327:1490-1495, 1992
PubMed
20) Misiani R, Bellavita P, Fenili D, et al:Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med 117:573-577, 1992
PubMed
21) Johnson RJ, Gretch DR, Yamabe H, et al:Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Eng J Med 328:465-470, 1993
 
22) Appel GB:Immune-complex glonlerulonephritis:deposits plus interest. N Eng J Med 328:505-506, 1993
 
23) Gocke DJ:Hepatitis A revisited. Ann Intern Med 105:960-961, 1986
PubMed
24) 古賀満明, 矢野右人:非A非B型急性肝炎, 肝炎の臨床像. 消化器科7:153-161, 1987
 
25) 与芝 真, 関山和彦:非A非B型亜急性肝炎, 同劇症肝炎とC型肝炎ウイルス. 日本臨牀49:412-419, 1991
 
26) Fauci AS, Haynes BF, Katz P:The spectrum of vasculitis. Clinical, pathologic, immunologic, and therapeutic considerations. Ann Intern Med 89:660-676, 1978
 
27) 吉川満喜男:インターフェロンとリウマチ病. リウマチ病セミナーIV (七川歡次監修), pp. 210-226, 大阪, 永井書店, 1993
 
P.45 掲載の参考文献
1) Klippel JH:Raynaud:s phenomenon. The french tricolor. Arch Intern Med 151:2389-2393, 1991
PubMed
2) Maricq HR, Carpentier PH, Weinrich MC, et al:Geographic variation in the prevalence of Raynaud's phenomenon;Charleston, SC, USA vs Tarentaise, Sovoie, France. J Rheumatol 20170-76, 1993
 
3) Riera G, Vilardell M, Vaque J, et al:Prevalence of Raynaud:s phenomenon in a healthy Spanish population. J Rheumatol 20:66-69, 1993
 
4) Harada N, Ueda A, Takegata S:Prevalence of Raynaud's phenomerlon in Japanese males and females. J Clin Epidemiol 44:649-655, 1991
 
5) Bartelink ML, Wollersheim H, van de Lisdonk E, et al:Prevalence of Raynaud:s phenomenon. Neth J Med 41:149-152, 1992
PubMed
6) Lally EV:Raynaud:s phenomenon. Curr Opin Rheumatol 4:825-836, 1992
PubMed
7) Kallenberg CGM:Early detection of connective tissue disease in patients with Raynaud:s phenomenon. Rheum Dis Clin North Am 16:11-30, 1990
 
8) LeRoy EC, Medsger TA Jr:Raynaud:s phenomenon:a proposal for classification. Clin Exp Rheumatol 10:485-488, 1992
PubMed
9) Maricq HR, LeRoy EC, D:Angelo WA, et al:Dignostic potential of in vivo capillary microscopy in scleroderma and related disorders. Arthritis Rheum 23:183-189, 1980
 
10) Maricq HR, Spencer-Green G, LeRoy EC:Skin capillary abnormalities as indicators of organ involvement in scleroderma (systemic sclerosis), Raynaud's syndrome and dermatomyositis. Am J Med 61:862-868, 1986
 
11) 森俊二:強皮症診断の手引き (難病医学研究財団編), p. 11, 岐阜, 大正製薬, 1990
 
12) Takehara K, Soma Y, Ishibashi Y:Early detection of scleroderma spectrum disorders in patients with Raynaud's phenomenon. Dermatologica 183:164-168, 1991
PubMed
13) Sato S, Takehara K, Soma Y, et al:Diagnostic significance of nailfold bleeding in scleroderma spectrum disorders, J Am Acad Dermatol 28:198-203, 1993
PubMed
14) Cleophas TJM, Niemeyer MG:Raynaud:s syndrome, an enigma after 130 years. Angiology 44:196-209, 1993
 
15) 梅村敏, 平和伸仁, 小林俊一, ほか:交感神経α受容体の分子生物学と本態性高血圧症. 日本臨牀 51:1591-1601, 1993
Medical*Online
16) Yanagisawa M, Kurihara H, Kimura S, et al:A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332:411-415, 1988
PubMed
17) 平田結喜緒:エンドセリン・エンドセリン受容体系の生理的・病態生理学的役割. 日本臨牀51:1540-1547, 1993
 
18) Knock GA, Terenghi G, Bunker CB, et al:Characterization of endothelin-binding sites in human skin and their regulation in primary Raynaud's phenomenon and systemic sclerosis, J Invest Dermatol 101:73-78, 1993
PubMed
19) Bedarida GV, Kim D, Blaschke TF, et al:Venodilation in Raynaud's disease. Lancet 342:1451-1454, 1993
 
20) Cleophas TJM, van Lier HJJ, Fennis JFM, et al:Finger temperature after a finger cooling test. Influence of air temperature, and cigarette smoking. J Appl Physiol 52:1167-1171, 1982
 
21) Bartelink ML, Wollersheim H, Leesmans E, et al:A standarized finger cooling test for Raynaud:s phenomenon:diagnostic value and sex differences. Eur Heart J 14:614-622, 1993
 
P.54 掲載の参考文献
1) 大田寛, 七川歡次, 前田晃, 他:慢性関節リウマチの死因調査, 平成4年度特定疾患調査研究結果報告書. 骨23～42:大阪府特定疾患研究会, 1993
 
2) 大田寛:慢性関節リウマチの死因と寿命. リウマチ病セミナーIII (七川歡次監修), pp. 85-94, 大阪, 永井書店, 1993
 
3) Pincus T, Callahan L F:Taking mortarity in rheumatoid arthritis serieusly. J Rheumatol 13:841-845, 1986
 
4) Gorden PA, Stein J L, Broden I:The extra-articular features of rheumatoid arthritis:a systematic analysis of 127 cases. Am J Med 54:445-452. 1973
 
5) Monson RR, Hall AP:Mortality among arthritis. Ann Rhuem Dis 29:459-467, 1976
 
6) Lewis P, Hazleman BL, Hanka R, et al:Cause of death in patients with rheumatoid arthritis with paticular reference to Azathioprine. Ann Rheum Dis 39:457-461. 1980
 
7) Rasker JJ, Cosh JA:Cause and age at death in a prospective study of 100 patients with rheumatoid arthtitis. Ann Rhuem Dis 40:115-120, 1981
 
8) Cosh JA, Rasker JJ:A20 year follow up study of 100 patients with rheumatoid arthritis. Ann Rheum Dis 41:317, 1982
 
9) Allebeck P:Increased mortality in rheumatoid arthritis. Scand J Rheum 11:81-86, 1982
PubMed
10) Vandenbroucke JP, Hazevoet HM, Cats A:Survival and cause of death in rheumtoid arthritis. J Rheumatol 11:158-161, 1984
 
11) Pincus T, Callahan LF, Sale WG, et al:Severe functional decline, work disability, and increased mortality in seventy-five rehumatoid arthritis patients studied over nine years. Arthritis Rheum 27:864-872, 1984
 
12) Mutru O, Laaskso M, Isomaki H, et al:Ten year mortality and causes of death in patients with rheumatoid arthritis. Br Med J 290:1797-1799, 1985
 
13) Isacson J, Allander E, Brostrom IA:Aseventeen year follow up of a population survey of rheumatoid arthritis. Scand J Rheumatol 16:145-152. 1987
 
14) Erhardt CC, Mumford PA, Venabes PRW, et al:Factors predicting a poor life progreses in rheumatoid arthritis:an eight year prospective study. Ann Rheum Dis 48:7-13, 1989
 
15) Jacobson LTH, Knowker WC, Pillemer S, et al:Rheumatoid arthritis and mortality:a longitudinal study in Pima indians. Arthritis Rheum 36:1045-1053, 1993
 
16) Hochberg MC:Predidicting the prognosis of patients with rheumatoid arthritis:is there a crystal ball? J Rheumatol 20:1265-1267, 1993
 
17) Isacson J, Allender E, Brastrom LA:A seventeen year follow up of a population survey of rheumatoid arthritis. Scand J Rheumatol 16:145-152. 1987
 
18) Eberhardt KB, Truedsson L, Pettersson H, et al:Disease activity and joint damage progression in early rheumatoid arthritis:relation to IgG, IgA, and IgM rhtumatoid factor. Ann Rhem Dis 49:906-909, 1990
 
19) Sherrer YS, Bloch DA, Mitchell DM, et al:The development of disability in rheumatoid arthritis. Arthritis Rheum 29:494-500, 1986
PubMed
20) Cosh JA:Survival and death in rheumatoid arthritis. J Rheuamtol 11:117-119, 1984
PubMed
21) Pinals RB:Survival in rheumatoid arthritis. Arthritis Rheum 30:473-475, 1987
 
22) Duthie JJR, Brown PE, Knox JDE, et al:Course and prognosis of rheumatoid arthritis. Ann Rheum Dis 16:411-422, 1957
 
23) Jacoby RA, Jayson MIV, Cosy JA:Onset, early stage and prognosis of rheumatoid arthritis. Br Med J 2:96-100, 1973
 
24) Scott DL, Symmons DPW, Culton PL, et al:Long term outcome of treating rheumatoid arthritis. Lancet 1:1108-1111, 1987
 
25) Reilly PA, Cosh JA, Maddison PJ, et al:Mortality and survival in rheumatoid arthritis:a 25 year prospective study of 100 patients. Ann Rheum Dis 49:363-369, 1990
PubMed
26) Lichtenstein MJ, Pincus T:Rheumatoid arthritis identified in population based cross sectional studies:low prevalence of rheumatoid factor. J Rhematol 18:989-993, 1991
PubMed
27) O'Sullivan JB, Cathcart ES:The prevalence of rheumatoid arthritis:follow up evaluation of the effect of criteria on rates in Suddeny, Massachusetts. Ann Intern Med 76:573-577, 1972
PubMed
28) Jacobson LTH, Knowker WC, Pillemer S, et al:Rheumatoid arthritis and mortality. Arthritis Rheum 36:1045-1053, 1993
 
29) 武仲善孝, 七川歡次, 大田寛, ほか:慢性関節リウマチ長期的予後. 第70回中部日本整形外科災害外科学会, 988
 
30) Cobbs S, Anderson F, Bawer W:Length of life and cause of death in rheumatoid arthritis. N Engl J Med 249:553-556. 1953
 
31) Pincus T, Callahan LF, Sale WG, et al:Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum 27:864-872, 1984
PubMed
32) van Zeben D, Hazes JMW, Zwinderman AH, et al:Association of HLA-DR 4 with a more progressive disease course in patients with rheumatoid arthritis. Arthritis Rheum 34:822-830, 1991
 
33) van Zeben D, Hazes JMW, Zwinderman AH, et al:Factors predicting outocome of rheumatoid arthritis:results of a follow up study. J Rheumatol 20:1288-1296, 1993
 
34) van Zeben D, Hazes JMW, Breedveld FC, et al:Which clinical variables contribute to the physician:s assessment of medium term outcome in rheumatoid arthritis. J Rheumatol 20:33-39, 1993
 
35) Bywaters EGL, Curwen M, Dresner E, et al:10 year follow up study of rheumatoid arthritis. Ann Rheum Dis 20:198, 1961
 
36) Cats A, Hazevoet HM:Significance of possitive tests for rheumatoid factor in the prognosis of rheumatoid arthritis. Ann Rheum Dis 29:254-259, 1964
 
37) Sharp JT, Calkins E, Cohen AS, et al:Observation on the clinica1, chemical, and serological manfestations of rheumatoid arthritis, based on the course of 154 cases. Ann Rheum Dis 29:254-259, 964
 
38) Dawer PT, Fowber PD, Jackson R, et al:Prediction of progressive joint damage in patients with rheumatoid arthritis receiving gold or D-penicillamine therapy. Ann Rheum Dis 45:945-949, 1986
PubMed
39) Kazis LE, Andersson JJ, Meenan RF:Health status as a predictor of mortality in rheumatoid arthritis:a five year study. J Rheumatol 17:609-613, 1990
 
40) Pincus T, Callahan LF, Vaughn WK:Questionaire, walking time and button test measures of functional capacity as predictive markers for mortality in rheumatoid arthritis. J Rheuamtol 14:240-251, 1987
 
41) 前田晃:早期RAの手・足の変形予防に対する長期臨床研究 (第8報). 平成4年度特定疾患調査研究結果報告書 (大阪府). 骨69-76, 1993
 
42) Deigton CM, Wentzel J, Cavanagh G, et al:Contribution of inherited factors to rheumatoid arthritis. Ann Rheum Dis 51:182-185, 1992
 
43) Weyland:Homozygosity for the HLA-DRB 1 allele selects for extra articular manifestations in rheumatoid arthritis. J Clin Invest 89:2033-2039, 1992
 
44) ansom DM, Anin SM, Bidwell JT, et al:HLA-DQ related restriction fragment length porymorphism in rheumatoid arthritis. Br J Rheum 28:374-378, 1994
 
45) Hillarby MC, Clarkson R, Grennan DM, et al:Immunogenetic heterogenesity in rheumatoid disease as illustrated by different MHC association (DQ, DW, and C4) in articular and extra-articular subset. Br J Rheum 28:374-378, 1994
 
46) Jawahere O, Thompson W, Macregor AJ, et al:Homozygosity for the HLA-DR shared epitope contributes to the highest risk for rheumatoid arthritis concordance in identical twins. Arthritis Rheum 37:681-686, 1994
 
47) Nelson JL, Dugowson CE, Koepsell TD, et al:Rheumatoid factor, HLA-DR 4, and allelic variants of DRB 1 in women with recent-onset rheumatoid arthritis. Arthritis Rheum 37:673-689, 1994
 
48) Fleming A, Crown JM, Corbett M:Prognostic vallue of early features in rheumatic disease. Br Med J 1:1243-1245, 1976
 
49) Amos RS, Constable TJ, Crockson RA, et al:Rhuematoid arthritis:relation of serum reactive protein and eythrocyte sedimentation rates to radiographic changes. Br Med J 1:195-197, 1977
 
50) Wawrzynska-Pagowska J, Brzezinska B, Brzozowska M, et al:Observations on the symptomes and signs of"early"rheumatoid arthritis in a prospective study. Acta Rheum Scand 16:99-105, 1970
 
51) Sjoblom KG, Saxne T, Dettersson H, et al:Factors related to progressive to joint destructions in rheumatoid arthritis. Scand J Rheumatol 13:21-27, 1984
 
52) Ochi T, Yonemasu K, Iwase R, et al:Serum Clq levels as a prognostic guide anticular erosions in patients with rheumatoid arthritis. Arthritis Rheum 27:883-887, 1984
 
53) Brook A, Fleming A, Corbett M:Relationship of radiological change to clinical outcome in rheumatoid arthritis, Ann Rheum Dis 36:274-275, 1977
PubMed
54) Deighron CM, McDonagh J, Walker DJ:Rheumatoid arthritis, nodules and HLA-linkage. Arthritis Rheum 36:9 (Suppl), 1993
 
55) Jarvinen P, Koskenvuo M, Kaskimies S, et al:Rheumatoid arthritis in identical twins:a clinical and immunegenetic study of eight concordant pairs derived from a nationwide twin panel. Scand J Rheumatol 20:159-164, 1991
 
56) Calin A:The epidemiology of rheumatoid disease:past and present. Dis Makers 4:1-2, 1986
 
57) Silman AJ:The genetic epidemiology of rheumatoid arthritis. Clin Exp Rheumatol 10:309-312, 1992
PubMed
58) Bellamy N, Deffy D, Martin N, et al;Rheumatoid arthritis in twins:a study of etiopathognesis based on the Australian Twin Registry. Ann Rheum Dis 19:588-593, 1992
 
59) Kohsaka H, Taniguchi A, Chen PP, et al:The expressed T cell recepter V gene repertoire of rheumatoid arthritis monozygotic twin:rapid analysis by anchored polymerase chain reaction and enzyme-liked immunosorbent assay. Eur J Immunol 23:1895-1901, 1993
 
60) Kohsaka H, Chen PP, Taniguchi A, et al:Divergent T cell receptor γ repertoires in rheumatoid arthritismonozygotic twins. Arthritis Rheum 36:213-221, 1993
 
61) Wingrave SJ, Kay CR:Reduction in incidence of rheumatoid arthritis associated with oral contraceptives. Lancet 1:569-571, 1978
 
62) Vandenbroucke JP, Witteman JCM, Valkenburg HA, et al:Noncontraceptive hormone and rheumatoid arthritis in perimenopausal and postmenopausal woman. JAMA 255:1299-1303, 1986
 
63) Spector TD, Rorman E, Silman AJ:The pill, parity and rheumatoid arthritis. Arthritis Rheum 33:782-789, 1990
 
64) Hazes JMW, Dijkmans BAC, Vandenbroucke JP, et al:Reduction of the risk of rheumatoid arthritis among women who take oral contraceptives. Arthritis Rheum 33:173-179, 1990
 
65) Linos A, Worthington JW, O'Fallon WM, et al:Case-control study of rheumatoid arthritis and prior use of oral contraceptives. Lancet 1:1299-1300, 1983
PubMed
66) Allebeck P, Ahlbom A, Ljungstrow K, et al:Do oral contracdptives reduce the encidencdce fo rheumatoid arthritis. Scand J Rheumatol 13:140-146, 1984
 
67) Esdaile JM, Horwitz RI:Observation studes of cause-effect relationships:an analysis of methodologic problems as illustrated by the conflicting data for the role of oral contraceptives in the etiology of theumatoid arthritis. J Chron Dis 39:841-852, 1986
 
68) Hermandez-Avila M, Liang MH, Willett WC, et al:Exogenosus sex hormones and the risk of rheumatoid arthritis. Arthritis Rheum 33:947-953, 1990
 
69) van Zeben D, Hazes JMW, Vandenbroucke JP, et al:Diminished incidence of severe rheumatoid arthritis associated with oral contraceptive case. Arthritis Rheum 33:1462-14685, 1990
 
P.65 掲載の参考文献
1) Baker LRI, Mallinson WIW, Gregory MC, et al:Idiopathic retroperitoneal fibrosis. A retrospective analysis of 60 cases. Br J Urol 60:497-503, 1988
 
2) Wicks IP, Robertson MR, Murnaghan GF, et al:Idiopathic retroperitoneal fibrosis presenting with back pain. J Rheumatol 15:1572-1574, 1988
PubMed
3) Azais I, Roblot P, Barrier J, et al:Fibrose retroperitoneale idiopathique et spondylarthrite ankylosante. Rev Rhum 60:367-370, 1993
PubMed
4) Durst AL, Freund H, Rosemann E, et al:Mesenteric panniculitis:review of the literature and presentation of cases. Surgery 81:203-211, 1977
 
5) Perez-Fontan EJ, Soler R, Sanchez J, et al:Retractile mesenteritis involving the colon;barium enema, sonographic and CT findings. AJR 147:937-940. 1986
 
6) Schowengerdt CG, Suyemoto R, Main FB:Granulomatous and fibrous mediastinitis. A review and analysis of 180 cases. J Thorac Cardiovasc Surg 57:365-379, 1969
 
7) Rholl ks, Levit RG, Glazer HS:Magnetic resonance imaging of fibrosing mediastinitis. AJR 145:255-259, 1985
 
8) Wold LE, weiland LH:Tumefactive fibroinflammatory lesions of the head and neck. Am J Surg Pathol 7:477-482, 1983
PubMed
9) Rice DH, Batsakis JG, Coulthard SW:Sclerosing cervicitis. Homologue of sclerosing retroperitonitis and mediastinitis. Arch Surg 110:120-122, 1975
PubMed
10) Fleischmajer R, Nedwich A, Reeves JRT:Juvenile fibromatoses. Arch Dermatol 107:574-579, 1973
 
11) Chaouat Y, Aron-Brunetire R, Faures B, et al:Une nouvelle entite;le rhumatisme fibloblastique. RevRhum 47:345-351, 1980
 
12) Chaouat Y, Binet O, Faures-Quinet B, et al:Le rhumatisme fibloblastique. Une entite clinique et histologique. Reu Rhum 55:59-62, 1988
 
13) Crouzet J, Amouroux J, Duterque M, et al:Rhumatisme fibloblastique. Un cas avec une etude dee:histologie synoviale. Rev Rhum 49:469-472, 1982
 
14) Levigne V, Perrot JL, Faisant M, et al:Rhumatisme fibloblastigne. Ann Dermatol venereol 117:199-202, 1990
PubMed
15) Taccari E, Teodori S, Zoppini A:Le rhumatisme fibroblastique du sujet age. Donnees histopathologiques, ulrastructurales et problemes de diagnostic differentiel. Rev Rhum 54:463-467, 1987
PubMed
16) Vignon-Pennamen MD, Naveau B, Foldes C, et al:Fibroblastic rheumatism. J Am Acad Dermatol 14:1086-1088, 1986
PubMed
17) Ziegler G, Ortonne JP, Milletre-Bernardin M, et al:Le rhumatisme fibloblastique:a propos d'un cas avec etude de cultures de fibroblastes. Rhumatologie 42:121-125, 1990
 
18) Bourgeois P, Cywiner-Golenzer Ch, Lessana-Leibowitch, et al:Les nodules sous-cutanes et tendineux dansla sclerodermie. Rev Rhum 43:85-91, 1976
 
19) James WD, Berger TG, Butler DF, et al:Nodular (Keloidal) scleroderma. J Am Acad Dermatol 11:1111-1114, 1984
PubMed
20) Gianotti F, Ermacora E, Magrini U:Fibromatose hyaline juvenile. Ann Derm Venereol 104:152-153
 

骨関節, 脊椎, 神経

P.76 掲載の参考文献
1) 本郷一郎:結合組織炎症候群. リウマチ病セミナーI (七川歡次監修), pp. 95-111, 大阪, 永井書店, 1990
 
2) Wolfe F, Smythe H A, Yunus M B, et al:The american colledge of rheumatology 1990 criteria for the classification of fibromyalgia.-Report of the multicenter criteria committee. Arthritis Rhrum 33:160-172, 1990
 
3) Smythe H A::Fibrositis:as a disorder of pain modulation. Clin Rheum Dis 5:823-832, 1979
 
4) Granges G, Littlejohn G:Pressure pain threshold in pain-free subjects, in patients with chronic regional pain syndromes, and in patients with fibromyalgia syndrome. Arthritis Rheum 36:642-645, 1993
PubMed
5) Granges G, Littlejohn G:A comparative study of clinical signs in fibromyalgia/fibrositis syndrome, healthy and exercising subjects. J Rheumatol 20:344-351, 1993
PubMed
6) Vaeroy H, Helle R, Forre O, et al:Cerebrospinal fluid levels of β-endorphin in patients with fibromyalgia (fibrositis syndrome). J Rheumatol 15:1804-1806, 1988
 
7) Russel IJ, Vaeroy H, Javors M, et al:Cerebrospinal fluid biogenic amine metabolites in fibromya1gia/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum 35:550-556, 1992
 
8) Russel IJ, Michallek JE, Vipraio GA, et al:Platelet 3H-Imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome. J Rheumatol 19:104-109, 1992
 
9) Goldenberg D L:An overview of psychologic studies in fibromyalgia. J Rheumatol 16 (Suppl 19):12-14, 1989
 
10) Vaeroy H, Sakurada T, Forre O, et al:Modulation of pain in fibromyalgia (fibrositis syndrome):cerebrospinal fluid (CSF) investigation of pain related neuropeptides with special reference to calcitonin gene related peptide (CGRP). J Rheumatol 16 (Suppl 19):94-97, 1989
 
11) Vaeroy H, Qiao Z, Morkrid L, et al:Altered sympathtic nervous system response in patients with fibromyalgia (fibrositis syndrome). J Rheumatol 16:1460-1465, 1989
 
12) Muller W:The fibrositis syndrome:diagnosis and pathogenesis. Scand J Rheumatol (Supp165):40-53, 1987
 
13) Moldofsky H:Sleep and fibrosiitis syndrome. Rheum Dis Clin North Am 15:91-103, 1989
PubMed
14) Moldofsky H, Saskin P, Lue F A:Sleep and symptom in fibrositis syndrom after febrile illness. J Rheumatol 15:1701-1704, 1988
PubMed
15) Vaeroy H, Abrahamsen A, Forre O, et al:Treatment of fibromyalgia (fibrositis syndrome):a pararell double blind trial with carisoprodol, paracetamol and caffeine (somadrill comp) versus placebo. Clin Rheumatol 8:245-250, 1989
 
16) Klug GA, McAuley E, Clark S:Factor influencing the development and maintenance of aerobic fittnes:Lessons applicable to the fibrositis syndrome. J Rheumatol 16 (Suppl 19):30-39, 1989
 
17) McCarty DJ, Csuka M, McCarty G, et al:Treatment of pain due to fibromalgia with topical capsaicin:a pilot study. Semin Arthritis Rheum 23 (Suppl 3):41-47, 1994
 
P.102 掲載の参考文献
1) De Palma AF:Surgery of the shoulder (3rd ed). Philadelphia, JB Lippincott, 1983
 
2) Neer CS II:Impingement lesions. Clin Orthop 173:70-77, 1983
 
3) Kessel L, Watson M:The painful arc syndrome. Clinical classification as a guide to management. J Bone Joint Surg 59-B:166-172, 1977
 
4) Matsen FA III, Arntz CT:Subacromial Impingement. In the Shoulder, (Ed, Rockwood CA Jr, Matsen FA III), pp. 623-646, Philadelphia, WB Saunders, 1990
 
5) 尾崎二郎, 中田浩司, 辰己英章, ほか:腱板表層 (滑液包側) 不全断裂の病態と手術. 肩関節17:330-333, 1993
 
6) Neer CS II, Welsh RP:The shoulder in sports. Orthop Clin North Am 8:583-591, 1977
 
7) 林田賢治, 米田 稔, 福島 直:投球障害肩に対する肩峰下滑液包内および肩関節内局麻剤ブロックテスト (投球テスト)の診断的価値. 第20回日本肩関節学会, 長崎市, 1993, 10
 
8) 米田 稔, 妻木範行, 山本利美雄, ほか:投球障害肩の治療. 整災外34:1153-1159, 1991
 
9) 米田 稔, 脇谷滋之, 広岡 淳, ほか:肩関節上方臼蓋唇損傷例の臨床的検討. 整外スポーツ医会誌 7:127-130, 1988
 
10) Rubin SA, Gray RL, Green WR:The scapular " Y":adiagnostic aid in shoulder trauma. Radiology 110:725-726, 1974
 
11) 米田 稔, 福島 直:肩関節軟部組織の画像診断-腱板および周囲組織を中心に. リウマチ病セミナーIV (七川歡次監修), pp. 115-131, 大阪, 永井書店, 1993
 
12) 福島 直, 米田 稔, 林田賢治ほか:肩峰インピンジメント症候群におけるMRI評価-Peribursal fat plane像の意義. 第20回日本肩関節学会, 長崎市, 1993, 10
 
13) Neer CS II:Anterior acromioplasty for the chronic impingement syndrome in the shoulder. A preliminary report. J Bone Joint Surg 54-A:41-50, 1972
 
14) Raggio CL, Warren RF, Sculco T:Surgical treatment of impingement syndrome:four year follow up. Orthop Trans 9:48, 1985
 
15) Thorling J, Bjerneld H, Hallin G, et al:Acromioplasty for impingement syndrome. Acta Orthop Scand 56:147-148, 1985
PubMed
16) Ellman H:Arthroscopic subacromial decompression:a preliminary report. Orthop Trans 9:49, 1985
 
17) Helming P, Sojbjerg JO, Anderson PK:Distal humeral migration as a component of multidirectional shoulder instability. Clin Orthop 252:139-143, 1990
 
18) Constant CR, Murley AHG:A clinical method of functional assessment of the shoulder. Clin Orthop 214:160-164, 1987
 
19) 林田賢治, 米田 稔, 岡村健司, ほか:腱板関節面不全断裂に対する手術療法-鏡視下デブライドメントと腱板修復術の比較. 肩関節17:315-319, 1993
 
20) 青木光広, 石井清一, 薄井正道:肩峰の傾斜の臨床計測 Subacromial impingement syndromeとの関係. 肩関負行 14:270-274, 1990
 
21) Bigliani LU, Morrison DS, April EW:The morphology of the acromion and its relationship to rotator cuff tears. Orthop Trans 10:216, 1986
 
22) Wuh HCK, Snyder SJ, Delpizzo W et al:A modified classification system of the arch view based on the anatomic thickness of the acromion. Submitted to AOSSM Annual Meeting, Orlando, FL, 1991
 
23) Rockwood CA, Lyons FR:Shoulder Impingment syndrome;Diagnosis, radiographic evaluation, and treatment with a modified Neer acromioplasty. J Bone Joint Surg 75-A:409-424, 1993
PubMed
P.110 掲載の参考文献
1) Goldwait JE:The rib joint. N Engl J M 223:568-573, 1940
 
2) Raney FL Jr:Radiculitis of the costovertebral joints. J Bone Joint Surg 48A:1016-1017, 1966
 
3) Raney FL Jr:Costovertebral-costotransverse joint complex as the source of local or referred pain, J Bone Joint Surg 48A:1451-1452, 1966
 
4) Roux Ch, Benhamou CL, Gervais T, et al:Arthrose costo-vertebrale revelee par des douleurs pseudoviscerales. Rev Rhum 56:191-195, 1989
 
5) Benhamou CL, Roux Ch, Benhamou-Mayoux A, et al:Arthrite costovertebrales inferieures de la pelvispondylite rhumatismale. Revelation pseudourologique. Rev Rhum 54:203-207, 1987
 
6) 辻本正記:前胸壁の痛み. リウマチ病セミナーIV (七川歡次監修), pp. 78-86, 大阪, 永井書店, 1993
 
7) Nathan H, weinberg H, Robin GC, et al:The costovertebral joints. Anatomical-clinical observations in arthritis. Arthritis Rheum 7:228-240, 1964
PubMed
8) Weinberg H, Nathan H, Magora F, et al:Arthritis of the first costo-vertebral joint as a cause of thoracic outlet syndrome. Clin orthop 86:159-163, 1972
 
9) Benhamou CL, Roux Ch, Gervaist, et al:Costovertebral arthropathy. Diagnosis and therapeutic value of arthrography. Clin Rheum 7:220-223, 1988
 
10) Malons AJ, Fischer MS, Locke JL:Stress related rib and vertebral changes. Radiology 170:117-119, 1989
 
11) 七川歡次, 西林保朗:RAの脊椎病変-診断と治療. 胸椎. 関節の外科11:60-64, 1984
 
P.119 掲載の参考文献
1) Brostrom L:Sprained ankles:III. Clinical observations in recent ligament ruptures. Acta Chir Scand 130:560-569, 1965
 
2) Kannus P, Renstrom P:Current concepts review:Treatment for acute tears of the lateral ligaments of the ankle. J Bone Joint Surg 73-A:305-312, 1991
 
3) Kleiger B:Mechanisms of ankle injury. Orthop Clin North Am 5:127-146. 1974
PubMed
4) Harper MC:The deltoid ligament:an evaluation of need for surgical repair. Clin Orthop 226:156-168, 1988
PubMed
5) Hopkinson WJ, St Pierre P, Ryan JB, et al:Syndesmosis sprains of the ankle. Foot&Ankle 10:325-330, 1990
PubMed
6) Black HM, Brand RL, Eichelberger MR:An improved technique for the evaluation of ligamentous injury in severe ankle sprains. Am J Sports Med 6:276-282, 1978
PubMed
7) Grace DL:Lateral ankle ligament injuries:inversion and anterior stress radiography. Clin Orthop 183:153-159, 1984
PubMed
8) Glasgow M, Jackson A, Jamieson AM:Instability of the ankle after injury to the lateral ligament. J Bone Joint Surg 62-B:196-200, 1980
 
9) 野村栄貴, 泉田重雄, 野口哲夫:正常人の足関節弛緩. 整形外科39:815-821, 1988
 
10) Rijke AM, Goitz HT, McCue FC, et al:Magnetic resonance imaging of injury to the lateral ankle ligaments. Am J Sports Med 21:528-534, 1993
 
11) 町田英一, 今村安秀, 丸山 公, ほか:超音波断層像を用いた新鮮足関節外側靭帯損傷の診断. 日整会誌 65 (2):S317, 1991
 
12) Colville MR, Marder RA, Boyle JJ, et al.:Strain measurement in lateral ankle ligaments. Am J Sports Med 18:196-200, 1990
PubMed
13) 大関 覚, 安田和則, 黒沢秀樹, ほか:足関節内・外側側副靭帯の同時歪み計測と定量的解析. 日整会誌 62 (7):S646, 1988
 
14) 大関 覚, 安田和則, 金田清志, ほか:足関節運動に伴う靭帯のひずみ計測-第5報-距骨下関節の内外反運動に伴う足関節外側靭帯のひずみ分布と解剖学的靭帯再建術. 日本足の外科学会雑誌13:74-77, 1992
 
15) 大関 覚, 安田和則, 金田清志, ほか:足関節再建靭帯のIsometry. 日整会誌63 (7):S1245, 1989
 
16) Sefton GK, George J, Fitton JM, et al:Reconstruction of the anterior talofibular ligament for the treatment of the unstable ankle. J Bone Joint Surg 61-B:352-354, 1979
 
17) Kjaersgaard-Andersen P, Wethelund J-O, Nielsen S:Lateral talocalcaneal instability following section of the calcaneofibular ligament:a kinesiologic study. Foot&Ankle 7:355-361, 1987
PubMed
18) 多賀一郎, 史野根生, 井上雅裕, ほか:外側靭帯切離による足関節前後不安定性の増大:足関節不安定性測定装置による計測. 日整会誌 66 (8):S1343, 1992
 
19) Attarian DE, McCrackin HJ, DeVito DP, et al:Biomechanical characteristics of human ankle ligaments. Foot&Ankel 6:54-58, 1985
 
20) Horibe S, Shino K, Taga I, et al:Reconstruction of lateral ligaments of the ankle with allogeneic tendon grafts. J Bone Joint Surg 73-B:802-805, 1991
 
21) 多賀一郎, 史野根生, 井上雅裕, ほか:足関節外側靭帯再建術:解剖学的再建法. 臨床整形外科26:35-42, 1991
 
22) 多賀一郎, 史野根生, 井上雅裕, ほか:自家大腿筋膜を用いた足関節外側靭帯の解剖学的再建術. 日本足の外科学会雑誌13:89-91, 1992
 
23) 多賀一郎, 史野根生, 井上雅裕, ほか:足関節靭帯損傷に合併する関節軟骨損傷:関節鏡所見. 臨床整形外科26:1021-1027, 1991
 
24) Taga I, Shino K, Inoue M, et al:Articular cartilage lesions in ankles with lateral ligament injury.:an arthroscopic study. Am J Sports Med 21:120-127, 1993
PubMed
25) Harrington KD:Degenerative arthritis of the ankle secondary to long-standing lateral ligament instability. J Bone Joint Surg 61-A:354-361, 1979
 
26) 多賀一郎, 史野根生, 堀部秀二, ほか:陳旧性足関節靭帯損傷における骨シンチ所見, 日関外誌9:41-44, 1990
 
27) Thompson JP, Loomer RL:Osteochondral lesions of the talus in a sports medicine clinic:a new radiographic technique and surgical approach. Am J Sports Med l 2:460-463, 1984
 
28) McCarroll JR, Schrader JW, Shelbourne KD, et al:Meniscoid lesions of the ankle in soccer players. Am J Sports Med 15:255-257, 1987
PubMed
29) Thein R, Eichenblat M:Arthroscopic treatment of sports-related synovitis of the ankle. Am J Sports Med 20:496-498, 1992
PubMed
P.131 掲載の参考文献
1) Resnick D, Niwayama G:Degenerative disease of the spine. In Diagnosis of Bone and Joint Disorders, pp. 1368-1415, Philadelphia, Saunders, 1981
 
2) 竹光義治, 原田吉雄, 熱田裕司, ほか:中・高年齢者の腰部変性後弯. 別冊整形外科12:18-21, 1987
 
3) Takemitsu Y, Harada Y, Iwahara T, et al:Lumbar degenerative kyphosis. Spine 13:1317-1326, 1988
PubMed
4) 竹光義治, 加茂裕樹, 熱田裕司, ほか:高齢者の各種脊柱後弯と腰痛. 整・災外36:901-907, 1993
 
5) 竹光義治:脊椎およびその周辺からの痛み-脊柱姿勢の異常に関連して-. 日本脊椎外科学会雑誌4:327-339, 1993
 
6) 戸山芳昭, 長山信幸, 田中耕一, ほか:骨粗鬆症に伴う脊椎圧迫骨折と脊柱変形. 別冊整形外科12:7-13, 1987
 
7) 大川 淳, 請川 洋, 宮沢あかね, ほか:高齢者の腰曲がり歩行と腰椎アライメント. 臨整外28:887-893 1993
 
8) 有田親史, 小林郁雄:老人の脊柱変形の分析. 臨整外15:115-122, 1980
 
9) 安藤正明, 山本博司, 中谷 孝, ほか:農村部における高齢者の腰痛と姿勢.別冊整形外科12:14-17, 1987
 
10) 仲田和正, 岩谷 力, 関谷 仁:高齢者の姿勢. その分類とメカニズム. 別冊整形外科, 12:2-6, 1987.
 
11) Rosen JC, Frymoyer JW:A review of camptocormia and an unusual case in the female. Spine 10:325-327, 1985
 
12) Laroche M, Delisle MB, Mazieres B, et al:Myopathie tardive localisee aux muscles spinaux:une cause de cyphose lombaire acquise de l'adulte. Rev Rhum 58:829-838, 1991
 
13) Hilliquin P, Menkes CJ, Laoussadi S, et al:Camptocormie du sujet age. Une nouvelle entite par atteinte des muscles paravertebraux. Rev Rhum 59:169-175, 1992
PubMed
14) Poullin P, Daumen-Legre V, Serratrice G:La camptocormie du sujet age:myopathie ou dystonie musculaire?. Rev Rhum 60:159-161, 1993
PubMed
15) 阿部修治, 西林保朗, 難波江止浩, ほか:慢性関節リウマチ患者に生じた脊椎前屈症. 日本脊椎外科学会雑誌5:124, 1994
 
16) 平泉 裕, 佐藤秀二, 杉本 太, ほか:高齢者の脊柱変形と疼痛. 整形外科45:1193-1200, 1994
 
17) 竹光義治:脊柱の姿勢異常. 神中整形外科学各論第21版 (天児民和編), pp. 73-137, 東京, 南山堂, 1990
 
18) Tveit P, Daggfeldt K, Hetland S, et al:Erector spinae lever arm length variations with changes in spinal curvature. Spine 19:199-204, 1994
 
19) 廣畑和志:慢性関節リウマチの骨粗鬆症の成因. 整形外科 MOOK 34:240-249, 1984
 
20) Steinberg VL, Parry CBW:Electromyographic changes in rheumatoid arthritis. Brit Med J 1:630-652, 1961
 
21) 原田義昭, 市橋研一, 川井和夫, ほか:慢性関節リウマチにおける筋萎縮の研究- Single Fiber EMGの応用-中部整災誌28:243-244, 1985
 
22) 原田義昭, 司馬良一, 廣畑和志, ほか:慢性関節リウマチにおける筋萎縮の研究-中枢神経系からの筋活動の抑制効果について-関節外科8:97-102, 1989
 
23) 李 俊煕, 大井淑雄, 中村耕二:腰椎椎間板変性の体幹筋力に及ぼす影響. 臨整外 29:837-840, 1994
 
24) Cooper RG, Stokes MJ, Sweet C, et al:Increased central drive during fatiguing contractions of the paraspinal muscles in patients with chronic low back pain. Spine 18:610-616, 1993
PubMed
25) Peck D, Nicholls PJ, Beard C, et al:Are there compartment syndromes in some patients with idiopathic back pain? Spine 11:468-475, 1986
PubMed
26) Cooper RG:Understanding paraspinal muscle dysfunction in low back pain:a way forward? Ann Rheum Dis 52:413-415, 1993
PubMed
27) Hadar H, Gadoth N, Heifetz M:Fatty replacement of lower paraspinal muscles:normal and neuromuscular disorders. Am J Roentgenol 141:895-898, 1983
 
28) Mayer TG, Vanharanta H, Gatchel RJ, et al:Comparison of CT scan muscle measurements and isokinetic trunk strength in postoperative patients. Spine 14:33-36, 1989
PubMed
29) 近藤 司, 秋山寛治:退行期骨粗鬆症における傍脊柱筋群の萎縮-CT像による検討-臨整外 28:1357-1363, 1993
 
30) 古泉 豊, 伊礼 修, 石橋賢太郎, ほか:腰痛疾患における腹・背筋筋力とQCTによる筋量測定. 理学診療5:165-172, 1994
 
31) Parkkola R, Rytokoski U, Kormano M:Magnetic resonance imaging of the discs and trunk muscles in patients with chronic low back pain and healthy control subjects. Spine, 18:830-836, 1993.
PubMed
32) Flicker PL, Fleckenstein JL, Ferry K, et al:Lumbar muscle usage in chronic low back pain. Magnetic resonance image evaluation. Spine 18:582-586, 1993
PubMed
33) 武政龍一, 山本博司, 谷 俊一, ほか:慢性腰痛に対する体幹筋強化訓練.理学診療 5:90-95, 1994
 
34) Rantanen J, Hurme M, Falck B, et al:The lumbar multifidus muscle five years after surgery for a lumbar intervertebral disc herniation. Spine 18:568-574, 1993
PubMed
35) 中尾俊憲, 渡辺英夫, 浅見豊子, ほか:腰部変性後湾に対するリュックサック型装具の試み. 理学診療 4:91-94, 1993
 
36) 上好昭孝:オステオポローシスとエストロジェン. リウマチ病セミナーIV (七川歡次監修), pp. 67-77, 大阪, 永井書店, 1993
 
P.140 掲載の参考文献
1) Weeks C:Occasional communications between the synovial sacs of knee and proximal tibiofibular joints. J Bone Joint Surg 4:798-800, 1930
 
2) Ogden JA:The anatomy and function of the proximal tibiofibular joint. Clin Orthop 101:186-191, 1974
PubMed
3) 戸松泰介, ほか:腓骨高位について. 日整会誌 55:1074-1075, 1979
 
4) Rojanasthien S, Okamoto R, Ozawa N, et al:Tibial plateau fibular head distance of normal measured in lateral view of roentgenogram. J Jpn Orthop Assoc 63:1353-1357, 1989
 
5) Lord D, Coutts JW:A study of typical parachut injuries occurring in two hundred and fifty thousand jumps at the parachute school. J Bone Joint Surg 26:547-557, 1944
 
6) Turco VJ, Spinella AJ:Anterolateral dislocation of the head of the fibulainsports. Am J Sports Med 13:209-215, 1985
PubMed
7) Ogden JA:Subluxation and dislocation of the proximal tibiofibular joint. J Bone Joint Surg 56-A:145-154, 1973
 
8) Molitor PJA, Dandy DJ:Permanent anterior dislocation of the proximal tibiofibular joint. J Bone Joint Surg 71-B:240-241, 1989
 
9) Keogh P, Masterson E, Murphy B, et al:The role of radiography and computed tomography in the diagnosis of acute dislocation of the proximal tibiofibular joint. Br J Radiol 66:108-111, 1993
 
10) Baciu CC, Tudor A, Olaru I:Recurrent luxation of the superior tibio-fibular joint in the adult. Acta Orthop Scand 45:772-777, 1974
PubMed
11) Giachino AA:Recurent dislocation of the proximal tibiofibular joint. J Bone Joint Surg 68-A:1104-1105, 1986
 
12) 野本聡, ほか:Scaffold型補強用 mesh (Leeds-Keio) による反復性近位脛腓関節脱臼の1治験例. 整・災外 33:1207-1210, 1990
 
13) Helfet A:Disorder of the Knee. 2nd ed., pp. 104-112, Philadelphia, Lippincott, 1982
 
14) Eichenblat M, Nathan H:The proximal tibio fibular joint. Int Orthop 7:31-39, 1983
PubMed
15) Veth RPH, Klasen HJ, Kingma LM:Traumatic instability of the proximal tibiofibular joint. Injury 13:159-164, 1981
 
16) Ledingham JM, Preston BJ, Doherty M:Cystic change in the head of the fibula in osteoarthritis. J Bone Joint Surg 75-B:429-432, 1992
 
17) Resnick D, Newell JD, Guerra J, et al:Proximal tibiofibular joint:anatomic-pathologic-radiographic correlation. Am J Roentgenol 131:133-138, 1978
 
18) Ishikawa H, Hirohata K:Bilateral peroneal nerve palsy secondary to dislocation of the proximal tibiofibular joint in rheumatoid arthritis. Rheumatol Int 5:45-47, 1984
PubMed
19) Resnick D, Niwayama G:Diagnosis of Bone and Joint Disorders, pp. 1085, Philadelphia, WB Saunders Comp, 1981
 
20) Weiss C, Averbuch PF, Steiner GC, et al:Synovial chondromatosis and instability of the proximal tibiofibular joint. Clin Orthop 108:187-190, 1975
PubMed
21)Barrie HJ, Barrington TW, Colwill JC, et al:Ganglion migrans of the proximal tibiofibular joint causing lesions in the subcutaneous tissue, muscle, bone, or peroneal nerve. Clin Orthop 149:211-215, 980
PubMed
P.145 掲載の参考文献
1) Santavirta S, Slatis P, Kankaanpaa U, et al:Treatment of the cervical spine in rheumatoid arthritis. J Bone Joint Surg 70-A:658-667, 1988
PubMed
2) Santavirta S, Konttinen YT, Laasonen E, et al:Ten-year results of operations for rheumatoid cervical spine disorders. J Bone Joint Surg 73-B:116-120, 1991
 
3) Clark CR, Getz DD, Menezes AH:Arthrodesis of the cervical spine in rheumatoid arthritis. J Bone Joint Surg 71-A:381-392, 1989
 
4) Hukuda S, Katsuura A:Operations for subluxation of the cervical spine in the patients with rheumatoid arthritis. A transition from short fusion to long fusion. Orthop Intern Ed 2:118-124, 1994
 
5) 大田寛:慢性関節リウマチ患者の死因と寿命. リウマチ病セミナーIII (七川歡次監修), pp. 85-94, 大阪, 永井書店, 1992
 
6) Santavirta S, Konttinen YT, Sandelin J, et al:Operations for the unstable cervical spine in rhuematoid arthritis, Sixteen cases of subaxial subluxation. Acta Orthop Scand 61:106-110, 1990
 
7) Awerbuch MS, Henderson DRF, Millazo SC, et al:Longterm follow-up of posterior cervical fusion for atlantoaxial subluxation in rheumatoid arthritis. J Rheumatol 8:423-432, 1981
 
8) Redlund-Johnell I, Pettersson H:Subaxial antero-posterior dislocation of the cervical spine in rheumatoid arthritis. Scand J Rheumatology 14:355-363, 1985
 
9) Kraus DR, Peppelman WC, Agarwal AK, et al:Incidence of subaxial subluxation in patients with generalized rheumatoid arthritis who have had previous occipital cervical fusions. Spine 16:S486-489, 1991
PubMed
10) Agarwal AK, Peppelman WC, Kraus DR, et al:Recurrence of cervical spine instability in rheumatoid arthritis following previous fusion:can disease progression be prevented by early surgery? J Rheumatol 19:1364-1370, 1992
 
11) Ochi T, Iwase R, Yonemasu K, et al:Natural course of joint destruction and fluctuation of serum Clq level in parients with rhuematoid arthritis. Arthritis Rheum 31:37-43, 1988
 
12) 藤原桂樹, 越智隆弘, ほか:慢性関節リウマチに伴う上位頸椎病変の自然経過. 臨床整形外科 24:551-556, 1989
 
P.158 掲載の参考文献
1) Keegan JJ:The Cause of dissociated motor loss in the upper extremity with cervical spondylosis. J Neurosurg 23:528-536:1965
 
2) 大田 寛, 小野啓郎:頸椎症に伴う解離性の上肢運動麻痺 ("dissociated motor loss"after Keegan)の臨床ならびに病理像. 第3回脊椎外科研究会抄録, p.17, 昭和50年 (1975) 6月8日, 大阪
 
3) 黒田 宏, 藤原郁郎, 森竹財三ほか:肩脾上肢型麻痺を来した頸椎骨軟骨症. 第3回脊椎外科研究会抄録, p.17, 昭和50年 (1975) 6月8日大阪
 
4) 大田 寛, 小野啓郎:頸椎症に伴う解離性の上肢運動麻痺. 臨整外10:1124-1132, 1975
 
5) 伊藤達雄, 辻 陽雄, 玉置哲也, ほか:頸椎疾患における Dissociated Motor Loss (Keegan)の臨床的検討. 日整会誌 54:135-151, 1980
 
6) 広藤栄一, 漆谷英礼, 糸数万正, ほか:頸椎症の解離性運動麻痺 (いわゆるKeegan type)の2症例. 中部整災誌 23:1023-1032, 1980
 
7) 田口敏彦, 河合伸也, 松岡 彰, ほか:Keegan型頸椎症の治療成績の検討. 整形外科と災害外科 39:1131-1134, 1991
 
8) 河合武司, 富田勝郎, 梅田真一郎, ほか:Keegan型頸椎症の治療経験. 整形外科 39:1665-1672, 1988
 
9) 荒木淑朗, 石田 実:<シンポジウム:Cervical spondylosis と神経症状> 1) Cervical spondylosisの臨床的およびX線学的研究. 臨床神経学 6:586-596:1966
 
10) Brain WR, Northfield D, Wilkinson M:The neurological manifestations of cervical spondylosis. Brain 75:187-225, 1952
PubMed
11) 中西孝雄, 坂口 亮:<シンポジウム:Cervical spondylosis と神経症状>2) 病態生理と筋電図. 臨床神経学 6 597-603, 1966
 
12) 小山正信, 服部 奨, 河内山 正, ほか:上肢帯の筋萎縮を主徴とする頸部脊椎骨軟骨症の症例. 中部整災誌 17:1095, 1974
 
13) 古川武光, 馬渕宣男, 青木正人, ほか:運動系の障害を主徴とする Cervical spondylosis (motor type) 3例の検討. 中部整災誌 18:677-678, 1975
 
14) 祖父江逸郎, 加藤寿雄, 柳 務:頸部脊椎症性ミエロパチーの臨床像と病型. 臨整外 10:999-1006, 1975
 
15) 大田 寛, 荻野 洋:頸椎症にみられた解離性の上肢運動麻痺. 整形外科 Mook 6:41-48, 1979
 
16) 安藤栄一, 田中清介, 糸数万正ほか:頸椎症の解離性運動麻痺 (Keegan type). 別冊整形外科 2:18-24, 1982
 
17) 大田 寛:関節症の有病率に関する調査研究-特にX線的股関節症を中心に-. 日整会誌 53:165-180, 1979
Medical*Online
18) 野口耕司, 飯田寛和, 林 泰一, ほか:頸椎症による dissociated motor loss syndrome 手術例の検討. 臨整外 17 1087-1098, 1982
 
19) 添田修一, 里見和彦, 平林 洌:頸武脊椎症筋萎縮例の筋萎縮型からみた病態について. 整形外科37:421-432, 1986
 
20) 市原健一, 森 健躬:頸椎症に伴う上肢麻痺の検討. 整形外科 38:453-460, 1987
 
21) 秋山典彦, 北尾 進, 坂西英夫, ほか:筋萎縮を主症状とする頸椎症の検討. 整形外科 36:461-468, 1987
 
22) 森下益多郎, 権藤 宏:頸椎症における dissociated motor loss syndromeの検討. Journal of Joint Surgery 11:113-123, 1992
 
23) Kotani H, Saiki K, Yamasaki H, et al:Evaluation of cervical cord function in cervical spondylotic myelopathy and/or radicuropathy using both segmental conductive spinal evoked potentials (SEP). Spine 11:185-190, 1986
PubMed
24) 秋山典彦, 北村 創, 吉村義之, ほか:上肢の解離性運動麻痺を示した頸椎症の1剖検例. 日整会誌 54:303-310, 1980
 
25) 古川浩三郎, 倉持英輔, 白沢栄嗣, ほか:頸部脊椎症性筋萎縮 (祖父江) 症例の経験. 臨整外 13:1152-1156, 1978
 
26) 西原伸治, 中原進之介, 田辺剛造, ほか:上肢の筋萎縮を主症とする頸部脊椎症の病態と治療成績. 臨整外 19:389-394, 1984
 
27) 若狭雅彦, 馬場逸志, 石田了久, ほか:肩関節運動障害を主症状とする頸椎疾患の検討. 中部整災誌 31:1338-1342, 1988
 
28) 林浩一郎:頸椎の臨床解剖. 整形外科 28:153-168, 1977
 
29) 都築暢之, 田中弘美, 星地亜都司, ほか:頸椎後方除圧術後に生じた神経根障害とその成因に関する解剖学的研究. 日整会誌 61:S652, 1987
 
30) 萬年 徹:老年者における脊髄の血管性障害に関する研究. 臨床神経 3:47-63, 1963
 
31) 武田芳嗣, 寺前俊樹, 大田耕司, ほか:頸椎症性筋萎縮症の手術後悪化例中部整災誌 32:2463-2465, 1989
 
32) 角家 暁, 大橋雅広, 広瀬源二郎, ほか:上肢筋の萎縮を主徴とする Cervical spondylosis. 脳神経外科 9:59-64, 1981
 
33) 柳 務, 安藤i哲朗:神経内科的疾患を合併する脊髄症の鑑別診断. 第82回中部日本整形外科災害外科学会抄録, p.102, 平成6年3月31日-4月1日, 和歌山市
 
34) 森澤 豊, 貞広哲郎, 谷 俊一, ほか:肩関節障害における神経疾患の問題点-特に Dissociated motor loss syndrome を中心として-. 肩関節 13:84-90, 1989
 
35) 斉鹿 稔, 河合伸也, 土井一輝, ほか:頸椎症性筋萎縮症 (Keegan型麻痺)の術式選択. 中部整災誌 36:1551-1552, 1993
 
36) 辻本 荘, 鈴木俊久, 山本 茂, ほか:著明な筋萎縮を伴った Cervical spondylosisの治療経験. 中部整災誌 21:1197-1199, 1978
 
37) 樋笠 端, 山岡賢見, 辻 博三:当院における頸椎症性筋萎縮症例の臨床的検討. 整形外科と災害外科 36:428-433, 1987
 
38) 植田百合人, 西山茂晴, 玉井進, ほか:上肢の筋萎縮を主徴とする頸髄症に対する除圧術の検討. 中部整災誌 33:1107-1108, 1990
 
39) 今村健志, 酒匂 崇, 松永俊二, ほか:Dissociated Motor Lossの臨床と病態. 日整会誌 67:S567, 1993 (第66回日本整形外科学会学術集会抄録II, 1993年5月, 神戸市)
 
40) 和田英路, 岩崎幹季, 小田剛紀, ほか:頸椎症筋萎縮症 (近位型および遠位型)の臨床的検討-椎弓形成術の治療成績から見た病態について-. 日整会誌 67:S564, 1993 (第66回日本整形外科学会学術集会抄録II, 1993年5月, 神戸市)
 

検査法

P.169 掲載の参考文献
1) Hollander JL, McCarty DJ, and Rawson AJ:The" RA cell" or inclusion body cell. Bull Rheum. Dis 16:382-390, 1969
PubMed
2) Freemont AJ, Denton J:Disease distribution of synovial fluid mast cells and cytophagocytic mononuclearcells in inflammatory arthritis. Ann Rheum Dis 44:312-315, 1985
 
3) Schumacher H R:Joint involvement in progressive systemic sclerosis. Am J clin pathol 60:593-600, 1973
PubMed
4) Amor B et al:Eosinophilic monoarthritis and the significance of synovial fluid eosinophilia. Rev Rhum 51:75-80, 1984
 
5) Klofkorn RW, Lehman TJA:Eosinophilic synovial effusions complicating chronic utricaria and angioedema. Arthritis Rheum 25:708, 1982
 
6) Kay J, Andrew H, Eichenfield, et al:synovial fluid enosinophilia in Lyme disease. Arthritis Rheum 31:1384-1389, 1988
 
7) Freemont A J, Denton J, Chuk A, et al:Diagnostic value of synovial fluid microscopy:a reassment and nationalization. Ann Rheum Dis 50:101-107, 1991
 
8) Davis M J, Denton J, Freemont A J, et al:Comparison of serial synovial fluid cytology in rheumatoid arthritis:delineation of subgroups with prognostic implications. Ann Rheum Dis 47:559-562, 1988
PubMed
9) Gatter RA, Richmond JD:Predominance of synovial fluid lymphocyts in early rheumatoid arthritis. J Rheumatol 2:340-347, 1975
 
10) Amor B, Dougados M, Carlioz R, et al:Arthritis lymphocytaires. Etude de 54 cas dont 25 apparemment idiopathiques. Rev Rhum 50:507-513, 1983
PubMed
11) Utsinger PD, Hicks JT, and McLaughlin G E:Chronic lymphocytic arthritis. Arthritis Rheum 23:758-764, 1980
 
12) Afeltra A, Caleazzi M, et al:Expression of CD 69 antigen on synovial fluid T cell in patients with rhematoid arthritis and other chronic synovitis. Ann Rheum Dis 52:457-460, 1993
 
13) Schumacher HR, Reginato AJ:Atlas of Synovial Fluid Analysis and Cystal Identification, stained preparation, Malvern, Pennsylvania, Lea&Febigor, p.58, 1991
 
P.176 掲載の参考文献
1) 唐下博子, 一村光子, 崎山順子, ほか:RAテストRF. 綜合臨牀 40:1554-1557, 1991
 
2) 山本則満, 青木良雄:ラテックス凝集比濁法によるRF定量法. 臨床検査 31:610-616, 1987
 
3) 江崎一子, 延永 正:レーザーネフェロメクーによるリウマチ因子定量法の臨床的有川性. 臨床検査 28:205-207, 1984
 
4) 向田直史, 河合 忠:TIAによる RF定量法. 臨床検査 31:603-609, 1987
 
5) 小林茂人, 田嶋美智子, 橋本博史, ほか:リウマトイド因子-測定法の進歩と問題点. リウマチ 30:436-444, 1990
 
6) Hardy RR, Hayakawa K, Shimizu M, et al:Rheumatiod factor secretion from human Leu-1+B cells. Science 236:81-83, 1987
 
7) Moynier M, Abderrazik M, Didry C, et al:The B cell repertoire in rheumatoid artheritis. III. Preferential homing of rheumatoid factor-producing B cell precursors in the synovial fluid. Arthritis Rheum 35:49-54, 1992
 
8) Burastero SE, Casali P, Wilder RL, et al:Monoreactive high affinity and polyreactive low affinity rheumatoid factors are produced by CD 5+B cells from patients with rheumatiod arthritis. J Exp Med 168:1979-1992, 1988
 
9) Nakamura M, Burastero SE, Notkins AL, et al:Human monoclanal rheumatoid factor-like antibodies from CD 5 (Leu-1) +B cells are polyreactive. J Immunol 140:4180-4186, 1988
 
10) Agnello V, Arbetter A, de Kasep GI, et al:Evidence for a subset of rheumatiod factors that cross-react with DNA-histone and have a distinct cross-idiotype. J Exp Med 151:1514-1527, 1980
 
11) 箱田雅之, 石本 強, 林本さくら, ほか:RA滑膜における Monoreactive RF産生B細胞の選択的浸潤. 臨床免疫 23:1480-1487, 1991
 
12) Kunkel HG, Agnello V, Joslin FG, et al:Cross-idiotypic specificity among monoclonal IgM proteins with anit-r-globulin activity. J Exp Med 137:331-342, 1973
 
13) Kunkel HG, Winchester RJ, Joslin FG, et al:Similarities in the light chains of anti-r-globulins showing coss-idiotypic specificities. J Exp Med 139:128-136, 1974
 
14) Crowley JJ, Goldfien RD, Schrohenloher RE, et al:Incidence of three cross-reactive idiotypes on human rheumatoid factor paraproteins. J Immunol 140:3411-3418, 1988
PubMed
15) Wedgwood JF, Hatam L, Bonagura VR:Expression of large quantities of rheumatiod factor major cross-reactive idiotype in the serum of adults with seropositive rheumatoid Arthritis Arthritis Rheum 35:840-845, 1991
 
16) Ezaki I, Kanda H, Sakai K, et al:Restricted diversity of the variable region nucleotide sequences of the heavy and light chains of a human rheumatiod factor. Arthritis Rheum 34:3433-350, 1991
 
17) Pascual V, Randen I, Thompson K, et al:The complete nucleotide sequences of the heavy chain variable regions of six monospecific rheumatoid factors derived from Epstin-Barr Virus-transformed B cells isolated from the synovial tissue of patients with rheumatoid arthritis. J CIin Invest 86:1320-1328, 1990
 
18) Pereira P, Coutinho A:I-E-linked control of spontaneous rheumatoid factor production in normal mice. J Exp Med 170:1825-1835, 1989
 
19) Ermel RW, Kenny TP, Chen PP, et al:Molecular analysis of rheumatoid factors derived from rheumatoid synovium suggests an antigen-driven responce in inflamed joints. Arthritis Rheum 36:380-388, 1993
 
20) Wlee T, Lu EW, Huang EF, et al:Genetic analysis of self-associating immunoglobulin G rheumatoid factors from two rheumatoid synovia implicates an antigen-driven response. J Exp Med 175:831-842, 1992
 
21) He X, Goronzy J, Weyand C:Selective induction of rheumatoid factors by superantigens and human helper T cells. J Clin Invest 89:673-680, 1992
PubMed
22) Thomas R, Mcilraith M, Davis LS, et al:Rheumatiod synovium is enriched in CD 45 RBdim mature memory T cells that are potent helpers for B cell differentiation. Arthritis Rheum 35:1455-1465, 1992
 
23) 延永 正:リウマチ因子. 日本臨床免疫学会雑誌 8:173-183, 1985
 
24) Arnason JA, Jonsson TH, Brekkan A et al:Relation between bone erosions and rheumatoid factor isotype. Ann Rheum Dis 46:380-384, 1987
 
25) Cohen IR, Cooke A:Natural autoantibodies prevent autoimmune disease. Immunol Today 12:363-364, 1986
PubMed
26) Sievers K:The rheumatoid factors in definite rheumatoid arthritis. Acta Rheum Scand 9 (Suppl):1-121, 1965
 
27) Vaughan JH:Pathogenetic concepts and origins of rheumatoid factor in rheumatoid arthritis. Arthritis Rheum 36:1-6, 1993
PubMed
28) Ishikawa H, Smiley JD, Ziff M:Electron microscopic demonstration of immunoglobulin deposition in rheumatoid cartilage. Arthritis Rheum 18:563-576, 1975
PubMed
29) Cooke TD, Hurd ER, Jasin HE, et al:Identification of immunoglobulins and complement in rheumatoid articular collagenous tissues. Arthritis Rheum 18:541-551, 1975
PubMed
30) Winchester RJ, Agnello V, Kunkel HG:Gamma globulin complexes in synovial fluids of patients with rheumatoid arthritis:partial characterization and relationship to lowered complement levels. Clin Exp Immunol 6:689-706, 1970
PubMed
31) Burastero SE, Casali P, Wilder RL, et al:Monoreactive high affinity and polyreactive low affinity rheumatoid factors are produced by CD 5+B cells from patients with rheumatoid arthritis. J Exp Med 168:1979-1992, 1988
 
P.188 掲載の参考文献
1) 福永仁夫, 森田陸司:Dual energy x-ray absorptiometry. 骨ミネラル測定と骨粗鬆症 (森田陸司編), pp.145-149, 東京, メデイカルレビュー社, 1989
 
2) Mazess R, Collick B, Trempe J, et al:Performance evaluation of a dual-energy x-ray bone densitometer. Calcif Tissue Int 44:228-232, 1989
PubMed
3) Cullum ID, Ell PJ, Rynder JP:X-ray dual-photon absorptiometry:a new method for the measurement of bone density. Br J Radiol 62:587-592, 1989
 
4) 白木正孝:各種骨量測定法の実際. 4. DEXA法. The Bone 5:81-88, 1991
 
5) Kinoshita H, Danjyo S, Yammada H, et al:Epidemiology study on the bone mineral density of inhabitants in miyama village, Wakayama prefecture (part II). Bone mineral density of the spine and proximal femur. JBMM 9 (Suppl) 50-55, 1991
 
6) Sievanen H, Oja P, Vuori I:Precision of dual-energy x-ray absorptiometry in determining bone mineral density and content of various skeletal sites. J Nucl Med 33:1137-1142, 1992
 
7) Engh CA, McGovern T, BoByn JD, et al:A quantitative evaluation of periprosthetic bone-remodeling after cementless total hip arthoplasty. J bone Joint Surg 74-A:1009-1020, 1992
 
8) 今井弘子, 渡辺良, 友光達志, ほか:健常女性例における腰椎, 大腿骨近位部および橈骨のBone Mineral Densityの加令に伴う変化. 日骨形態誌 2:51-58, 1992
 
9) 藤原敏弘, 串田一博, 岡本庄造, ほか:大腿骨近位部骨塩量の検討-大腿骨頸部骨折と骨塩量-. 中部整災誌 33:975-976, 1990
 
10) 桜井隆, 東文造, 小味克己, ほか:人工股関節置換術後の大腿骨骨塩量-DEXAによる骨塩定量-. 中部整災誌 34:1715-1716, 1991
 
11) Engh CA, Bobyn JD, Glassman AH:Porous-coated hip replacement:the factors governing bone ingrowth, stress shielding, and clinical results. J Bone Joint Surg 69-B:45-55, 1987
 
12) 増原建作:股関節疾患患者の運動-患肢荷重と骨塩量-. 関節外科 12:2633-272, 1993
 
13) 豊島良太, 山本吉蔵, 岸本英雄, ほか:慢性関節リウマチにおける骨粗鬆化. 日整会誌 61:289-297, 1987
 
14) 萩野 浩, 山本吉蔵, 賀川 武, ほか:DEXA と SPAの測定結果の検討. 日骨形態誌 1:129-133, 1991
 
15) 谷口正和, 串田一博, 伝田正史, ほか:X-ray dual photon absorptiometry法よる第2中手骨骨塩量の検討. 中部整災誌 33:970-972, 1990
 
16) Eyres K, Bell MJ, Kanis JA:New bone formation during leg legthening. J Bone Joint Surg 75-B:96-106, 1993
 
17) 上里智美, 茨木邦夫, 乗松尋道, ほか:脛骨近位端部の骨塩量の検討. 整形外科・災害外科 37:121-124, 1988
 
18) 西野仁樹, 中村利孝, 黒沢尚, ほか:膝関節障害における大腿骨, 脛骨, 膝蓋骨骨塩量の変化. 日骨形態誌 1:37-43, 1991
 

生物学的反応

P.201 掲載の参考文献
1) 岡本光弘, 東城博雅:膵臓その他の消化器および脾臓由来ホスホリパーゼA2の構造と機能. 蛋白質核酸酵素 36:316-324, 1991
 
2) 工藤一郎:高等動物由来非膵型ホスホリパーゼA2の構造と機能. 蛋白質核酸酵素 36:325-332, 1991
 
3) Tojo H, Ono T, Kuramitsu S, et al:A phospholipase A2 in the supernatant fraction of rat spleen. Its similarity to rat pancreatic phospholipase A2 J Biol Chem 263:5724-5731, 1988
PubMed
4) Tojo H, Zhao Y, Okamoto M:Purification characterization of guinea pig gastric phospholipase A2 of the pancreatic type. Eur J Biochem 215:81-90, 1993
 
5) Arita H, Hanasaki K, Nakano T, et al:Novel proliferative effect of phospholipase A2 in Swiss 3T3 cells via specific binding site. J Biol Chem 266:19. 139-19141, 1991
 
6) Zhao Y, Tojo H, Nonaka Y, et al:Cloning and expression of phospholipase A2 from guinea pig gastric mucosa, its induction by carbachol and secretion in vivo. Eur J Biochem 215:91-97, 1993
 
7) Tojo H, Ono T, Okamoto M:High performance liquid chromatographic assay of phospholipases. Application to spectrophotometric detection of rat phospholipase A2 isozymes. J Lipid Res 34:837-844, 1993
PubMed
8) Nevalainen TJ, Haapanen TJ:Distribution of pancreatic (group I) and synovial-type (Group II) phospholipase A2 in human tissues. Inflammation 17:453-464, 1993
 
9) Clark JD, Lin L-L, Kriz RW, et al:A novel arachidonic acid-selective cytosolic PLA2 contain a Ca2+-dependent translocation domain with homology to PKC and GAP. Cell 65:1043-1051, 1991
PubMed
10) Fujimori Y, Murakami M, Kim DK, et al:Immunochemical detection of arachidonoyl-preferential phospholipase A2. J Biochem (Tokyo) 111:54-60, i 9. 92
 
11) Lyons-Giordano B, Davis GL, Galbraith W, et al:Interleukin-1 stimulates phospholipase A2 mRNA synthesis in rabbit articular chondrocytes. Biochem Biophys Res Commun 164:488-495, 1988
 
12) Hoeck WG, Ramesha CS, Chang DJ, et al:Cytoplasmic phospholipase A2 activity and gene expression are stimulated by tumor necrosis factor:dexamethasone blocks the induced synthesis. Proc Natl Acad Sci USA 90:4475-4479, 1993
PubMed
13) Pruzanski W, Vadas P:Phospholipase A2-a mediator between proximal and distal effectors of infiammation. Immunology Today 12:143-146, 1991
 
14) Nakano T, Ohara T, Teraoka H:Grucocorticoids suppress group II phospholipase A2 production by blocking mRNA synthesis and post-transcriptional expression. J Biol Chem 265:12745-12748, 1990
 
15) Bomalaski JS, Lawton P, Browning JL:Human extracellular recombinant phospholipase A2 induces an inflammatory response in rabbit joints. J Immunol 146:3904-3910, 1991
PubMed
16) Murakami M, Kudo I, Nakamura H, et al:Exacerbation of rat adjuvant arthritis by intradermal injection of purified mammalian 14-kDa group II phospholipase A2. FEBS Lett 268:113-116, 1990
PubMed
17) Murakami M, Kudo I, Inoue K:Eicosanoid generation from antigen-primed mast cells by extrarcellular mammalian 14-kDa group II phospholipase A2. FEBS Lett 294:247-251, 1991
PubMed
18) Wada A, Tojo H, Komatsubara T, et al:Group II phospholipase A2 enhances the mesangial proliferation. J Am Soc Nephrol 4:640, 1993
 
19) Lin L-L, Wartmann M, Lin AY, et al:cPLA2 is phosphorylated and activated by MAP kinase. Cell 72:269-278, 1993
PubMed
20) Ogawa m, Arakawa H, Yanlashita S, et al:Postoperative elevations of serum interleukin 6 and group phospholipase A? Group II phospholipase A? in serum is an acute phase reactant. Res Commun Chem Pathol Pharmacol 75:109-115, 1992
 
21) Minami T, Tojo H, Shinomura Y, et al:Raised serum activity of phospholipase A2 immunochemically related to group I enzyme in inflammatory bowel disease. Gut 33:914-921, 1992
 
22) Minami T, Tojo H, Shinomura Y, et al:Elevation of group II phospholipase A2 protein in sera of patients with Crohn:s disease and ulcerative colitis. Am J Gastroenterol 88:1076-1080, 1993
PubMed
23) Harvey RF, Bradshow JM:A simple index of Crohn's disease activity. Lancet 1:514, 1980
 
24) Matts SGF:The value of rectal biopsy in the diagnosis of ulcerative colitis. Q J Med 30:393-407, 1961
 
25) Minami T, Tojo H, Shinomura Y, et al:Increased group I phospholipase A2 in colonic mucosa of patients with Crohn's disease and ulcerative colitis. Gut:in press, 1994
 
26) Crowl RM, Stoller TJ, Conroy RR, et al:Induction of phospholipase A2 gene expression in human hepatoma cells by mediators of the acute phase response. J Biol Chem 266:2647-2651, 1991
PubMed
27) Inada M, Tojo H, Kawata S, et al:Preferential distribution of group II-like phospholipase A2 in mononuclear phagocytic cells in rat spleen and liver. Eur J Biochem 197:323-329, 1991
PubMed
28) Inada M, Tojo H, Kawata S, et al:Induction of group II-like phospholipase A2 by lipopolysaccharide in the liver of BCG-primed rat. Biochem Biophys Res Commun 174:1077-1083, 1991
PubMed
29) Hatch GM, Vance DE, Wilton DC:Rat liver mitochondrial phospholipase A2 is an endotoxin-stimulated membrane-associated enzyme of Kupffer cells which is released during liver perfusion. Biochem J 293:143-150, 1993
PubMed
P.210 掲載の参考文献
1) Love PE, Santoro SA:Antiphospholipid antibodies:anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Ann Intern Med 112:682-698, 1990
PubMed
2) Harris EN, Baguley E, Asherson RA, Hughes GRV:Clinical and serological features of the" antiphospholipid syndrome" (abstr). Br J Rheumatol 26 (Suppl 2):19-25, 1987
 
3) 志水正敏:抗カルジオリピン抗体症候群. リウマチ病セミナーII (七川歡次監修), pp.181-186, 大阪, 永井書店, 1991
 
4) McNeil HP, Simpson RJ, Chesterman CN, Krilis SA:Antiphospholipid antibodies are directed against a complex antigen that includes a lipid binding inhibitor of coagulation:β2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci 87:4120-4124, 1990
 
5) galli M, Comfurius P, Maassen C, at al:anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 335:1544-1547, 1990
 
6) Verrier Jones J, James H, Tan MH, et al:Antiphospholipid antibodies require β2-glycoprotein I (apolipoprotein H) as cofactor. J Rheumatol 19:1397-1402, 1992
 
7) Pangborn Mc:A new serologically active phospholipid from beaf heart. Proc Soc Exp Biol (NY) 48:484-486, 1941
 
8) Moore JE, Mohr CF:Biologically false positive serologic tests for syphilis:type, incidence, and cause. J Chronic Dis 150:467-473, 1952
 
9) Conley CL, Hartmann RC:Ahemorrhagic disorder caused by circulating anticoagulant in patients with disseminated lupus erythematosus. J Clin Invest 31:621-622, 1952
 
10) Harris EN, Boey ML, Gharavi AE, et al:Anticardiolipin antibodies:detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet:1211-1214, 1983
PubMed
11) Loizon S, McCrea JD, Rudge AC, et al:Measurement of anti-cardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA):standardization and quantitation of results. Clin Exp Immunol 62:738-745, 1985
 
12) Koike T, Sueishi M, Funaki H, et al:Antiphospholipid antibodies and biological false positive serological test for syphilis in patients with systemic lupus erythematosus, Clin Exp Immunol 56:193-199, 1984
 
13) McNeil HP, Chesterman CN, Krilis SA:Anticardiolipin antibodies and lupus anticoagulants comprise separate antibody subgroups with different phospholipid binding characteristics. Br J Haematol 73:506-513, 1989
PubMed
14) Rauch J, Tannenbaum M, Tannenbaum H, et al:Human hybridoma lupus anticoagulants distinguish between lemellar and hexagonal phase lipid systems. J Biol Chem 261:9672-9677, 1986
 
15) Rauch J, Janoff AS:Phospholipid in the hexagonal II Phase is immunogenic:evidence for immunorecognition of nonbilayer lipid phases in vivo. Proc Natl Acad Sci 87:4112-4114, 1990
PubMed
16) Harris EN, Hughes GRV:Antiphospholipid antibodies. In arthritis and allied conditions. A Textbook of Rheumatology (Ed, McCarty DJ), pp.1068-1079., Philadelphia, Lea and Febiger, 1989
 
17) Alarcon-Segovia D:Antiphospholipid antibodies and the antiphospholpid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients, Medicine 68:353-365, 1989
 
18) Asherson RA:Antiphospholipid antibodies and syndromes. In systemic lupus erythematosus (Ed Lahita RG), pp.587-635, New York, Churchill Livingstone, 1992
 
19) Alarcon-Segovia D:Clinical Manifestations of the antiphospholipid syndrome. J Rheumatol 19:1778-1781, 1992
 
20) Hughes GRV:The antiphospholipid syndrome;ten years on. Lancet 342:341-344, 1993
 
21) Lozier J, Takahashi N, Putnum FW:Complete amino acid sequence of human plasma β2-glycoprotein I. Proc Natl Acad Sci 81:3640-3644, 1984
 
22) Nimpf J, Wurm H, Kostner GM:β2-glycoprotein I (apo-H) inhibits the release reaction of human platelets during ADP-induced aggregation. Atherosclerosis 63:109-114, 1987
 
23) Schousboe I:β2-glycoprotein I:a plasma inhibitor of the contact activation of the intrinsic blood coagulation pathway. Blood 66:1086-1091, 1985
 
24) Nimpf J, Bevers EM, Bomans PH, et al:Prothrombinase activity of human platelets is inhibited by β2-glycoprotein I. Biochem Biophys Acta 884:142-146, 1986
 
25) Matsuura E, lgarashi Y, Fujimoto M, et al. Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor. J Immunol 148:3855-3891, 1992
 
26) Hunt JE, McNeil HP, Krilis SA:Aphospholipid-β2-glycoprotein-I complex is the antigen for anticardiolipin antibodies in antoimmune disease but not infections. Lupus 1:75-81, 1992
 
27) 小池隆夫, 松浦栄次:抗カルジオリピン抗体とその対応抗原. 免疫 94:106-116, 1993
 
28) Verrier Jones J:Antiphospholipid antibodies:New perspectives on antigenic specificity. J Rheumatol;19 1774-1777, 1992
 
29) Kra-Oz Z, Lorber M, Shoenfeld Y, et al:Inhibitor (s) of natural anti-cardiolipin autoantibodies. Clin Exp Immunol 93:265-268, 1993
PubMed
30) Harris EN, Pierangeli S, Banquinero J, et al:Anticandiolipin antibodies and binding of anionic phospholipids and serum protein (letter). Lancet 366:505-506, 1990.
 
31) Gharavi AE:Antiphospholipid cofactor, Stroke (Suppl 1) 23:7-10, 1992
 
32) Sammaritano LR, Lockshin MD, Gharavi AE:Antiphospholipid antibodies differ in aPL cofactor requirement. Lupus 1:83-90, 1992
PubMed
33) Sammaritano LR, Gharavi AE, Soberrano C, et al:Phospholipid binding of antiphospholipid antibody and placental anticoagulant protein. J Clin Immunol 12:27-35, 1992
 
P.222 掲載の参考文献
1) 仙波恵美子, 野口光一:疼痛と神経ペプチド-形態学的アプローチ-. ペインクリニック 10:39-49, 1989
 
2) 仙波恵美子:痛みと神経ペプチド. 綜合臨牀 42:470-476, 1993
 
3) 仙波恵美子:痛みの分子生物学-ペプチド発現と細胞性癌遺伝子-. ペインクリニック 12:17-24, 1991
 
4) 野口光一:痛みの物質-侵害刺激と神経ペプタイドーブレインサイエンス 3:51-60, 1992
 
5) 仙波恵美子:疼痛ストレスと細胞性癌遺伝子, 術後痛 (花岡一雄, 百瀬隆編), pp.166-201, 東京, 克誠堂, 1993
 
6) 仙波恵美子:痛みと遺伝子発現. ペインクリニック 14:523-531, 1993
 
7) 越智隆弘:癌遺伝子 (Oncogene). リウマチ病セミナーI (七川歡次監修), pp.194-202, 大阪, 永井書店, 1990
 
8) Levine JD, Dardick SJ, Roizen MF, et al:Contribution of sensory afferents and sympathetic efferents to joint injury in experimental arthritis. J Neurosci 6:3423-3429, 1986
PubMed
9) Lembeck F, Holzer P:Substance P as a neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation, Naunyn-Schmiedebergs Arch. Pharmacol 310:175-183, 1979
PubMed
10) Lembeck F, Donnerer J, Colpaert FC:Increase in substance P in primary afferent nerves during chronic pain. Neuropeptides 1:175-180, 1981
 
11) Levine DJ, Clark, R, Devor M, et al:Interneuronal substance P contributes to the severity of experimental arthritis. Science 226:547-549, 1984
 
12) Smith GD, Harmer AJ, McQueen DS, et al:Increase in substance P and CGRP, but not somatostatin content of innervating dorsal root ganglia in adjuvant monoarthritis in the rat. Neurosci Lett 137:257-260, 1992
 
13) Noguchi K, De Leon M, Nahin RL, et al:Quantification of axotomy-induced alteration of neuropeptide mRNAs in dorsal root ganglion neurons with special reference to neuropeptide Y mRNA and the effects of neonatal capsaicin treatment. J Neurosci Res 35:54-66, 1993
PubMed
14) Hokfelt T, Zhang X, Wiesenfeld-Hallin Z:Messenger plasticity in primary sensory neurons following axotomy and its functional implications. TINS 17:22-30, 1994
PubMed
15) Sluka KA, Westlund KN:An experimental arthritis in rats:dorsal horn aspartate and glutamate increases. Neurosci Lett 145:141-144, 1992
PubMed
16) Noguchi K, Kowalski K, Traub R, et al:Dynorphin expression and fos-like immunoreactivity following inflammation induced hyperalgesia are colocalized in spinal cord neurons. Mol Brain Res 5:227-233, 1991
 
17) Noguchi K, Dubner R, Ruda MA:Preproenkephalin mRNA in spinal dorsal horn neurons is induced by peripheral inflammation and is colocalized with Fos and Fos-related proteins. Neurosci 46:561-570, 1992
 
18) Noguchi K, Ruda MA:Gene regulation in an ascending nociceptive pathway:inflammation-induced increase in preprotachykinin mRNA in rat lamina I spinal projection neurons. J Neurosci 12:2563-2572, 1992
 
19) Draisci G, Iadarola MJ:Temporal analysis of increases in c-fos, preprodynorphin and preproenkephalin mRNAs in rat spinal cord. Mol Brain Res 6:31-37, 1989
 
20) Sheng M, McFadden G, Greenberg ME:Membrane depolarization and calcium induce c-fos transcription via phosphorylation of transcription factor CREB. Neuron 4:571-582, 1990
PubMed
21) Robertson HA:Immediate-early genes, neuronal plasticity, and memory. Biochem Cell Biol 70:729-737, 1992
PubMed
22) 野村信夫:c-fos遺伝子, c-jun遺伝子. 日本臨牀 48:1655-1661, 1990
Medical*Online
23) 日比正彦:シグナル伝達と転写因子 AP-1. 実験医学 11:961-967, 1993
Medical*Online
24) Aloe L, Tuveri MA, Carcassi U, et al:Nerve growth factor in the synovial fluid of patients with chronic arthritis. Arthritis Rheum 35:351-355, 1992
PubMed
25) Lindsay R M, Harmer A J:Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurons. Science 337:362-364, 1989
 
26) Bucala R, Ritchlin C, Winchester R, et al:Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblasts. J Exp Med 173:569-574, 1991
PubMed
27) Hashimoto S, Yamanaka K, Inoue A, et al:Preprotachikinin mRNA expression in the synovial tissue of chronic arthrtis. Reg Peptides 46:193-194, 1993
 
28) 高橋裕一, 塩飽浩美, 澤井高志:慢性滑膜細胞におけるproto-oncogeneの発現臨床免疫 23:1436, 1991
 
29) 黒木康雄, 塩沢俊一:c-fos遺伝子の発現と慢性関節リウマチ. 臨床免疫 25:277-284, 1993
 
30) Senba E, Doi M, Tokunaga A, et al:Interleukin-1 β-induced expression of immediate early genes in the HPA axis of the rat. Internat J Neurosci, in press.
 
31) Basbaum AI, Menetrey D, Presley R, et al:The contribution of the nervous system to experimental arthritis in the rat. In The arthritic rat as a model of clinical pain? (Ed, Besson JM and Guilbaud G), pp.41-53, Amsterdam, Elsevier, 1988
 
32) Senba E, Matsunaga K, Tohyama M, et al:Stress-induced c-fos expression in the rat brain:activation mechanism of sympathetic pathway. Brain Res Bull 31:329-344, 1993
PubMed
P.230 掲載の参考文献
1) 志水正敏:T細胞の分類. リウマチ病セミナーI (七川歡次監修), pp. 185～193, 大阪, 永井書店, 1990
 
2) Roitt IM, Brostoff J, Male DK:114～116, 202, 245～246 Immunology, pp.114～116, 202, 245～246, 東京, 南江堂 (日本語版), 1990
 
3) Abbas AK, Lichtman AH, Pober JS:Effector of cell-mediated immunity pp. 256～258, In Cellular and Molecular Immunology, 256～258, W B Saunbers, 1991
 
4) Suzuk N, Kansas G, Engleman EG:Lymphocytes:structure and function. In Arthritis and Allied Conditions, (Ed, Mc Carty DJ, Koopman WJ), pp.377～387, Philadelphia, Lea and Febiger, 1993
 
5) Lebow LT, Jewett A, Bonavida B:Killer cell recruitment and renewal capacity of purified cytolytic and non-cytolytic human peripheral blood natural killer cell subsets. J Immunol 150:320-329, 1993
 
6) Oshimi K:Granular lymphocyte proliferative disorders:report of 12 cases and review of the literature. Leukemia 2:617-627, 1988
PubMed
7) Loughran TP, Kadin ME, Starkebaum G, et al:Leukemia of large granular lymphocytes:association with clonal chromosomal abnormalities and autoimmune neutropenia, thrombocytopenia, and hemolytic anemia. Ann Intern Med 102:169-75, 1985
PubMed
8) Barton JC, Prasthofer EF, Egan ML, et al:Rheumatoid arthritis associated with expanded populations of granular lymphocytes. Ann Intern Med 103:357-362, 1985
 
9) Wallis WJ, Loughran TP, Kadin ME, et al:Polyarthritis and neutropenia associated with circulating large granular lymphocytes. Ann Intern Med 103:357-362, 1985
PubMed
10) Horwitz:Systemic lupus erythematosus:generalized autoimmunity arising from disorderd immune regulation. Arthritis and Allied Conditions (Ed, McCarty DJ, Koopman WJ), pp.1185～1199, Philadelphia, Lea and Febiger, 1993
 
11) Miyasaka N, Seaman W, Bakshi A, et al:Natural Killing activity in Sjogren's Syndrome:an analysis of defective mechanisms. Arth Rheum 26:954-960, 19. 83
 
12) Fox, RI, Hugli TE, Lanier LL, et al:Salivary gland lymphocytes in primary Sjogren's syndrome lack lymphocyte subsets defined by Leu-7 and Leu-11 antigens. J Immunal 135:207～214, 1985
 
13) 小林晏, 印部小月, 志水正敏, ほか:胃癌, SLEと若年性関節リウマチ患者末梢血のNK活性, ADCC活性およびLeu-7とLeu-11陽性細胞の相関性. 厚生年金病院年報 12:361～373, 1985
 
14) Hendrich C, Kuipers JG, Kolanus W, et al:Activation of CD16+effector cells by rheumatoid factor complex. Role of natural killer cells in rheumatoid arthritis. Arthritis Rheum 34:423-431, 1991
PubMed
15) Melejczyk JM, Malejczyk M, Urbanski A, Luger T:Production of natural killer cell activity-augmenting factor (interleukin-6) by human epiphyseal chondrocytes. Arthritis Rheum 35:706-713, 1992
 
16) 志水正敏:T 細胞レセプター. リウマチ病セミナーIV (七川歓次監修), pp.175～180, 大阪, 永井書店, 1993
 
P.240 掲載の参考文献
1) Marrack P, Kappler J:The staphylococcal enterotoxins and their relatives. Science 248:705-711, 1990
 
2) Johnson HM, Russell JK, Pontzer CH:Staphylococcal enterotoxin microbial superantigens. FASEB J 5:2706-2712, 1991
PubMed
3) White J, Herman A, Pullen AM, et al:The V β-specific superantigen staphylococcal enterotoxin B:Stimulation of mature T cells and clonal deletion in neonatal mice. Cell 56:27-35, 1989
 
4) Choi YW, Herman A, DiGiusto D, Wade T, Marrack P, Kappler J:Residues of the variable region of the T-cell receptor beta-chain that interact with S. aureus toxin superantigens. Nature 346:471-3, 1990
 
5) Pullen AM, Wade T, Marrack P, Kappler JW:Identification of the region of T cell receptor beta chain that interacts with the self-superantigen Mls-Ia. Cell 61:1365-74, 1990
 
6) Swaminathan S, Furey W, Pletcher J, Sax M:Crystal structure of staphylococcal enterotoxin B, a superantigen. Nature 359:801-805, 1992
PubMed
7) Karp DR, Teletski CL, Scholl P, Geha R, Long EO:The alpha 1 domain of the HLA-DR molecule is essential for high-affinity binding of the toxic shock syndrome toxin-1. Nature 346:474-6, 1990
PubMed
8) Karp DR, Long EO:Identification of HLA-DR 1 β chain residues critical for binding staphylococcal enterotoxins A and E. J Exp Med 175:415-424, 1992.
 
9) Dowd JE, Karp DR:Staphylococcal enterotoxins inhibit peptide specific T cell activation without development of anergy. Arthritis Rheum 36 (Suppl):s148 (abstract)
 
10) Janeway CA Jr:Are there cellular superantigens? Immunol Rev 131:189-200, 1993
PubMed
11) Janeway CA Jr:Mls:makes a little sense. Nature 349:459-461, 1991
 
12) Marrack P, Blackman M, Kushnir E, et al:The toxicity of staphylococcal enterotoxin B in mice is mediated by T cells. J Exp Med 171:455-464, 1990
 
13) Miethke T, Wahl C, Heeg K, et al:T cell-mediated lethal shock triggered in mice by the superantigen staphylococcal enterotoxin B;critical role of tumor necrosis factor. J Exp Med 175:91-98, 1992
PubMed
14) Kotb M, Ohnishi H, Majumdar G, et al:Temporal relationship of cytokine release by pheripheral blood mononuclear cells stimulated by the streptococcal superantigen pepM 5. Infect Immunity 61:1194-1201, 1993
 
15) Yoshihara R, Shiozawa S, Fujita T, Chihara K:Gamma interferon is produced by human natural killer cells but not T cells during Staphylococcus aureus stimulation. Infect Immunity 61:3117-3122, 1993
PubMed
16) Kawabe Y, Ochi A:Selective anergy of Vβ8+, CD4+ T cells in Staphyloccocus enterotoxin B-primed mice. J Exp Med 172:1065-1070, 1990
 
17) Kotzin BL, Leung DY, Kappler J, et al:Superantigens and their potential role in human disease. Adv Immucol 54:99-166, 1993.
PubMed
18) Paliard X, West SG, Lafferty JA, Kappler J, Marrack P, Kotzin BL:Evidence for the effects of a superantigen in rheumatoid arthritis. Science 253:325-329, 1991
PubMed
19) Brocke S, Gaur A, Piercy C, et al:Induction of relapsing paralysis in experimental autoimmune encephalomyelitis bybacterial superantigen. Nature 365:642-644, 1993
 
20) Rott O, Wekerle H, Fleischer B:Protection from experimental allergic encephalomyelitis by application of a bacterial superantigen. Int Immunol 4:347-53, 1992
PubMed
21) Kim C, Siminovitch KA, Ochi A:Reduction of lupus nephritis in MRL/1pr mice by a bacterial superantigen. J Exp Med 174:1431-1437, 1991
 
22) Anderson GD, Banerjee S, Luthra HS, David CS:Role of Mls-1 locus and clonaldeletion of T cells in susceptibility tocollagen-induced arthritis in mice. J Immunol 147:1189-1193, 1991
 
23) Cantor H, Crump AL, Raman VK, Liu H, Markowitz JS, Grusby MJ, Glimcher LH:Immunoregulatory effects of superantigens:interactions of staphylococcal enterotoxins with host MHC and non-MHC products. Immunol Rev 131:27-42, 1993
PubMed

治療と副作用

P.253 掲載の参考文献
1) Jaffe IA.:Rheumatoid arthritis with arteritis-report of a case treated with penicillamine. Ann Intern Med 61:556-563, 1964
PubMed
2) Camus JP, Crouzet J, Prier A, Bergevin H:Pyrithioxine and thiopronine:new penicillamine-like drugs in rheumatoid arthritis. J Rheumatol (Suppl 7) 8:175-177, 1981
 
3) Huskisson EC, Jaffe IA, Scott J, Dieppe PA:5-thiopyridoxine in rheumatoid arthritis:clinical and experimental studies. Arthritis Rheum 23:106-110, 1980
PubMed
4) Martin MF, et al:Captopril:A new treatment for rheumatoid arthritis? Lancet 16, 1325-1327, 1984
 
5) Shiokawa Y, Horiuchi Y, Homma M, et al:Clinical evaluation of D-penicillamine by multicentric double-blind comparative study in chronic rheumatoid arthritis. Arthritis Rheum 20:1462-1472, 1977
 
6) Pasero G, Pellegrini P, Ambanelli U, et al:Controlled multicenter trial of tiopronin and D-penicillamine for rheumatoid arthritis. Arthritis Rheum 25:923-929, 1982
 
7) 塩川優一, 小川暢也, 阿部千之, ほか:SA96の慢性関節リウマチに対する薬効検定-多施設協同二重盲検群間比較試験-. 医学のあゆみ 135:1116-1133, 1985
 
8) Howand HE, Lock CJL, Mewa A, et al:D-penicillamine:chemistry and clinical use in rheumatoid disease. Semin Arthritis Rheum 15:261-281, 1986
 
9) Lyle WH:Penicillamin, In Anti-rheumatic Drugs (Ed, Huskisson EL), pp.521-554, New York, Praeger, 1983
 
10) Lipsky PE:Suggested mode of action of D-penicillamine as an immunosuppressive agent in rheumatoid arthritis. Z. Rheumatol 47 (Suppl 1):6-8, 1988
 
11) Matsubara T, Saura R, Hirohata K, et al:Inhibition of human endothelial cell proliferation in vitro and neovascularisation in vivo by D-penicillamine. J Clin Invest 83:158-167, 1989
PubMed
12) 七川歡次, 武仲善孝, 葦原滋, ほか:チオプロニンの慢性関節リウマチに対する有効性の検討. リウマチ病班VII (七川歡次監修), pp.191-203, 永井書店, 大阪, 1984
 
13) Kay A:European League against Rheumatism study of adverse reactions to D-penicillamine. Br J Rheumatol 25:193-198, 1986
 
14) Hall C, Jawand S, Harrison PR, et al:Natural course of penicillamine nephropathy:along term study of 33 patients. Br med J 296:1083-1086, 1988
 
15) Joyce DA:D-penicillamine. Bailliere's Clin Rheumatol 3:553-574, 1990
 
16) Storch WB:Clinical significance of penicillamine antibodies. Lancet 2:214, 1988
PubMed
17) Speerstra F, Reekers P, Van de Putte LBA, et al:HLA-DR antigens and proteinuria induced by aurothioglucose and D-penicillamine in patients with rheumatoid arthritis. J Rheumatol 10:948-953, 1983
 
18) Chalmers A, Thompson D, Stein HE, et al:Systemic lupus erythematosus during penicillamine therapy for rheumatoid arthritis. Ann Intern Med 97:659-663, 1982
PubMed
19) 東 威, 菅原幸子, 前田晃, ほか:早期慢性関節リウマチに対する金, D-Pおよび非ス剤の長期比較臨床研究-1. 1年間の評価-. リウマチ26:200-209, 1986
 
20) Amor B, Mery C, Gery A:Tiopronin (N-2-mercaotopropionyl]glycin) in rheumatoid arthritis. Arthritis Rheum 25:698-70, 1982
PubMed
21) 延永正:慢性関節リウマチ. 第22回日本医学会総会会誌 (II), 東京:664-665, 1988
 
22) 宮地清光:慢性リウマチ (RA) に対するチオプロニンの効果. リウマチ 21:474, 1981
 
23) 小宅和俊, 安田正之, 大石省一, ほか:慢性関節リウマチに対するD-ペニシラミンとチオプロニンの有用性の比較. 九州リウマチ 6:156-160, 1987
 
24) Youinou P, Delecoeuillerie G, Fauquert P, et al:La tiopronine, un exemple de derives sulfhydryles utilisss dans le traitement de la polyarthrite rhumatoide. Etude des effets immunologiques. Rev Rhum 57:287-291, 1990
 
25) Lamour A, Paolozzi L, Leroux AM, et al:Polyarthrite rhumatoide:evolution des sous-populations lymphocytaires sous l'effet de la tiopronine Rev Rhum 59:525-575, 1992
 
26) Sany J, Combe B, Verdie-Petibon D, et al:Etude de la Tolerance a long terme de la thiopronine (Acadione) dans le traitement de la polyarthrite rhumatoide. A propos de 140 case personnels. Rev Rhum 57:105-111, 1990
 
27) Ehrhart A, Chicault P, Fanquert P, et al:Effet secondaires dus au traitement par la tiopronine de 74 polyarthrites rhumatoides. Rev Rhum 58:193-197, 1991
 
28) 七川歡次, 前田晃, 小松原良雄, ほか:慢性関節リウマチに対する低用量チオプロニンの薬効評価-多施設二重盲検比較試験-. 臨床リウマチ 6:50-63, 1994
 
29) Menkes CJ, Job-Deslandre C, Bauer-Vinassac D, et al:Myasthenie induite par la tiopronine au cours du traitement de la polyarthrite rhumatoide. Presse med 17:1156-1157, 1988
 
30) Koeger AC, Rozenberg S, Chaibi P, et al:Polymyosite induite par la tiopronine confirme par l'histologie, Rev Rhum 60:78-79, 1993
 
31) Berthelot JM, Lalande S, Chalier C, et al:Pneumopathie interstitielle. Tiopronine. Rev Rhum 61:204-207, 1994
 
32) Koeger AC, Palazzo E, Person JF, et al:Evolution subaigue de syndromes nephrotique dus a la tiopronine. Quatre observations. Rev Rhum 60:78, 1993
 
33) Katayama I, Nishioka K:Lupus like syndrome induced by 2-mercaptoproprionylglycine. Dermatologie 13:151-153, 1986
 
34) Sigaud M, Maugars Y, Maisonneuve H, et al:Tiopronine dans 69 cas de PR traites anterieurement par la D-penicillamine. Rev Rhum 55:467-471, 1988
 
35) Amor B, Mery C, Gercy A:L'acadione, un nouveau traitement de fond de la polyarthrite rhumatoide. Rev Rhum 55:462-466, 1988
 
36) Chossat E, Paolozzi L, Delecoeuillerie G, et al:Essai controle comparant tiopronine et sels d'or injectables dans le traitement de la polyarthrite rhumatoide. Rhumatologie 44:83-88, 1991
 
37) Paolozzi L, Brin S, Asch L, et al:Essai controle comparatif de l'efficacite et de la tolerance de la tiopronine et du methotrexate (MTX) dans la polyarthrite rhumatoide. Rev Rhum 60:651, A34, 1993
 
38) Hirohata S, Lipsky P:Regulation of B cell function by bucillamine, a novel disease-modifying antirheumatic drug. Clin Immunol Immunopath 66:43-51, 1993
 
39) 柳田たみ子, 宮下琢, 広畑俊成:Bucillamineの作用機序:SA-981のB細胞抑制機構の解析. リウマチ34:408, F123, 1994
 
40) Hashimoto K, Lipsky PE:Immunosuppression by the disease modifying antirheumatic drug bucillamine:inhibition of human T lymphocyte function by bucillamine and its metaboliyes. J Rhumatol 20:953-957, 1993
 
41) Eguchi K, Kawakami A, Ida H, et al:Bucillamine inhibits T cell adhesion to human endothelial cells. J Rheumatol 119:1045-1050, 1992
 
42) 三好孝生, 四宮文男, 岡田正彦, ほか:慢性関節リウマチに対するBucillamine 投与の有用性と, とくに副作用についての検討. リウマチ科 12:224-232, 1994
 
43) 佐藤昌志, 朝倉裕士, 日比謙一, ほか:ブシラミンによる腎障害の臨床・病理組織学的検討. 日本医事新報No. 3565:32-34, 1992
 
44) 根岸雅夫, 山崎純子, 穂坂路男, ほか:ブシラミン治療中に顆粒球減少症を発症した慢性関節リウマチの1症例. リウマチ 34:651-655, 1994
 
45) 根岸雅夫, 利修治, 笠問毅, ほか:Bucillamineによる肺障害-全国アンケート調査を基にして-. リウマチ 32:135-139, 1992
 
46) 瀬戸邦雄, 倉田典之, 川上郁子, ほか:ブシラミン腎症に対する臨床・免疫病理学的検討. リウマチ 31:679, W-25, 1991
 
47) 猪熊茂子, 坂田師通, 安藤純子, ほか:ブシラミンの副作用と免疫グロブリン減少. リウマチ33:316-324, 1993
 
48) 西澤芳男:ブシラミンの副作用早期発現法, リウマチ 34:409, F126, 1994
 
49) 種市幸二, 馬場嘉美, 酒井勲, ほか:慢性関節リウマチにおけるbucillamineに対するresponderのtree classification. リウマチ 34:408, F125. 1994
 
P.260 掲載の参考文献
1) Pincus T, Marcum SB, Callahan LF:Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practice;11, Second line drugs and prednisone. J Rheumatol 19:1885-1894, 1992
 
2) Weinblatt ME, Polisson R, Blother SD, et al:The effects of drug therapy on radiographic progression of rheumatoid arthritis. Arthritis Rheum 36:613-619, 1993
 
3) Willkens RF, Urowity MB, Stablein DM, et al:Comparison of agathioprine, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. Arthritis Rheum 35:849-856, 1992
 
4) 豊田嘉清, 松原 司, 廣畑和志:金剤に対するresponderとnon-responderとの識別に関する解析. 臨床リウマチ 3:316-320, 1990
 
5) 山木戸道郎, 武田政寛, 石岡伸一:RA患者末梢血単核球に対するDMARDの作用とその臨床効果との関連について. 平成4年度厚生省リウマチ調査研究事業研究報告書, 202-205, 1993
 
6) Jorgensen C, Rossi JF, Anaya JM, et al:Expression des genes de resistance multiple aux medicament (MDR 1) dans la synoviale rhumatoide, Rev Rheum 59:643, 1992
 
7) 武仲善孝, 七川歡次, 菊川美貴子, ほか:I a, I b, II, III, Mq 型B群溶連菌に対する慢性関節リウマチ, 多発付着部炎の血中型特異抗体の測定. 第35回日本リウマチ学会総会抄録集 234, 1991
 
8) 武仲善孝, 前田依子, 山端真美, ほか:慢性関節リウマチ患者の臨床経過に伴う抗B群溶連菌抗体の変動. リウマチ 33:707, 1993
 
P.265 掲載の参考文献
1) Scott DL, Symmons DPM, Coulton BL, et al:Long-term outcome of treating RA:results after twenty years. Lancet 8542:1108-1111, 1987-1.
 
2) Fries JF, Williams CA, Ra mey D, et al:The relative toxicity of desease modifying anti-rheumatic drugs. Arthritis Rheum, 36 (3):297-306, 1993
 
3) Edmonds JP, Scott DL, Furst DE, et al:Antirheumatic drugs:aproposed new classification. Arthritis Rheum, 36 (3):336-339, 1993
 
4) Firestein GS, Paine MM, Boyle DL:Mechanisms of methotrexate action in rheumatoid arthritis. Arthritis Rheum 37:(2) 193-200, 1994
PubMed
5) 佐伯 徹, 福本 学, 白川 茂, ほか:癌の薬剤耐性 (鶴尾 隆編). Mebio 10:8-52, 1993
 
6) Roninson IB, Chin J E, Choi K, et al:Isolation of human mdr DNA sequences amplified in multidrug resistant KB carcinoma cells. Proc Natl Acad Sci 83:4538-4542, 1986
PubMed
7) Yoshimura A, Kawazuru Y, Sumizawa T, et al:Cytoplasmic orientation and two-domain structure of the multi drug transporter, P-glycoprotein, demonstrated with sequence-specific antibodies. J Biol Chem 264:16282-16291, 1989
 
8) Jorgensen C, Rossi JF, Anaya JM, et al:Expression desgenesde resistance muliple aux medicaments (MDR1) dans lasynoviale rheumatoide. Rev Rhum 59:643, 1992
 
9) Takatori T, Ogura M, Tsunlo T:Purfication and characterization of NF-R2 that regulates the expression of the human multi drug resistance (MDR1) gene. Jpn J Cancer Res84 (3);298-303, 1993
 
10) Tsuruo T, Iida H, Tsukagoshi S, et al:Overcoming of vincristine resistance in P388 leukemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 41:1967-1972, 1981
PubMed
11) 藤井隆夫, 諏訪 昭, 吉田 正, ほか:慢性関節リウマチに対するオーラノフィンとサラゾスルファピリジン, メトトレキセートの併用療法の検討. リウマチ 34:571-582, 1994
 
12) Csuka ME, Carrera GF, McCarty DJ:Treatment of intractable rheumatoid arthritis with combined cyclophosphamide, azathioprine and hydroxychloroquine:a follow-up study. JAMA 255:2615-2319, 1986
 
P.275 掲載の参考文献
1) Fontana A, Hengartner H, Weber E, et al:Interleukin-1 activity in the synovial fluid of patients with rheumatoid arthritis. Rheumatol Int 2:49-53, 1982
PubMed
2) Chu CQ, Field M, Feldmann M, et al:Localization of tumor necrosis factor α in synovial tissues and at the cartilage-pannus junction in patients withrheumatoid arthritis. Arthritis Rheum 34:1125-1132, 1991
 
3) Eastgate JA, Symons JA, Wood NC, et al:Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis. Lancet 2:706-709, 1988
PubMed
4) Rooney M, Symons JA, Duff GW:Interleukin-1 beta in synovial fluid is related to local disease activity in rheumatoid arthritis. Rheumatol Int 10:217-219, 1990
PubMed
5) Pettipher ER, Higgs GA, Henderson B:Interleukin-1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. Proc Natl Acad Sci USA 83:8749-8753, 1986
PubMed
6) Henderson B, Pettipher ER:Arthritogenic actions of recombinant IL-1 and tumor necrosis factor α in the rabbit:evidence for synergistic interactions between cytokines in vivo. Clin Ext Immunol 75:306-310, 1989
 
7) Keffer J, Probert L, Cazlaris H, et al:Transgenic mice expressing human tumor necrosis factor:apredictive genetic model of arthritis. EMBO J 10:4025-4031, 1991
 
8) Schwab JH, Anderle SK, Brown RR, et al:Pro-and anti-inflammatory roles of interleukin-1 in recurrence of bacterial cell wall-induced arthritis in rats. Infection and Immunity 59:4436-4442, 1991
PubMed
9) Wooley PH, Whalen JD, Chapman DL, Berger AE, Richard KA, Aspar DG:The effect of an interleukin-1 receptor antagonist protein on type II collagen-induced arthritis and antigen-induced arthritis in mice. Arthritis Rheum 36:1305-1314, 1993
PubMed
10) Williams RO, Feldmann M, Maini RN:Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc Natl Acad Sci U S A 89:9784-9788, 1992
PubMed
11) Lebsack ME, Paul CC, Martindale JJ, et al:Adose-and regimen-rangingstudy of IL-1 receptor antagonist in patients with rheumatoid arthritis. Arthritis Rheum 36 (Suppl 9):S39, 1993
 
12) Elliott MJ, Maini RN, Feldmann M, et al:Treatment of rheumatoid arthritiswith chimeric monoclonal antibodies to tumor necrosis factor α. Arthritis Rheum 36:1681-1690, 1993
 
13) Arend WP, Dayer J-M:Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 33:305-315, 1990
 
14) Henderson B, Blake S:Therapeutic potential of cytokine manipulation. TIPS 131:145-152, 1992
 
15) Eisenberg SP, Evans RJ, Arrend WP, et al:Prim. ary structure and functional expression from complementary DNA of a human interleukin 1 receptor antagonist. Nature 343:341-346, 1990
 
16) Firestein GS, Berger AE, Tracey DE, et al:IL-1 receptor antagonist protein production and gene expression in rheumatoid arthritis and osteoarthritis synovium. J Immunol 149:1054-1062, 1992
PubMed
17) Malyak M, Swaney RE, Arrend WP:Levels of synovial fluid interleukin-1 receptor antagonist in rheumatoid arthritis and other arthropathies. Arthritis Rheum 36:781-789, 1993
 
18) Nophar Y, Kemper O, Brakebusch C, et al:Soluble forms of tumor necrosis factor receptors (TNF-Rs):the cDNA for the type I TNF-R, cloned using amino acid sequence data of its soluble form, encodes both the cell surface and a soluble forms of the receptor. EMBO J 9:3269-3278, 1990
 
19) Deleuran B, Chu CQ, Field M, et al:Localization of TNF receptor in the synovial tissue and cartilage/punnus junction in rheumatoid arthritis:implication for local actions of TNF-α. Arthritis Rheum 35:1170-1178, 1992
 
20) Cope A, Aderka D, Doherty M, et al:Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluids of patients with rheumatic diseases. Arthritis Rheum 35:1160-1169, 1992
PubMed
21) Thornberry NA, Bull HG, Calaycay JR, et al:A novel heterodimeric cystein protease is requiredfor interleukin-1 βprocessing in monocytes. Nature 356:768-774, 1992
 
22) Cerretti DP, Kozlosky CJ, Mosley B, et al:Molecular cloning of the interleukin-1βconverting enzyme. Science 256:97-100, 1992
 
23) Bandara G, Mueller GM, Galea-Lauri J, et al:Intraarticular expression of biologically active interleukin-1-receptor-antagonist protein by ex vivo gene transfer. Proc Natl Acad Sci U S A 90:10764-10768, 1993
PubMed
P.284 掲載の参考文献
1) Altman RD:Classification of disease:osteoarthritis Seminers in Arth Rheum 20 (Suppl 2):40-47, 1991
 
2) Jasin HE:Immunoparhogenesis of osteoarthritis:therapeutic opportunities 薬剤評価の新しい展開. 日本リウマチ財団薬効検定委員会シンポジウム記録, (日本リウマチ財団薬効検定委員会 編), pp. 159-163, 東京, 医科学出版, 1993
 
3) 新名正由, 吉原愛雄:OAの関節障害パラメーター薬物評価の新しい展開. 日本リウマチ財団薬効検定委員会シソポジウム記録, (日本リウマチ財団薬効検定委員会編), pp.166-171, 東京, 医科学出版1993
 
4) 景山孝正, 青木虎吉, 三好邦達, ほか:変形性膝関節症に対するHKP-210 (ケトプロフェン貼付剤)の臨床評価-基剤を対象薬とした二重盲検比較試験-薬理と治療 14:6653-6678, 1986
 
5) Kalbhen DA:Proteoglycan synthesis and caltilage protection in the hen model of osteoarthritis. In Diclofenenac and cartilage in osteoarthritis (Ed, Moskowitz R, Hirohat K), pp. 22-32, Hogrefe&Huber publishers, 1989
 
6) 津山直一, 原徹也, 赤坂嘉詰久, ほか:変形性膝関節症に対するarteparonの関節内注入療法. 臨床薬理12:39-49, 1981
 
7) 七川歓次, 前田晃, 小川鴨, ほか:変形関節症に対するピアルロン酸ナトリウム (SPH)の薬効検定. リウマチ 25:280-290, 1983
 
8) Gramajo RT, Cutreoneo ET, Fernandez DE, et al:A single-blind, placebo-controlled study of glycosaminoglycan-peptide comlex (Rumalon) in patients with osteoarthritis of hip or knee. Crrent Med Reseach and Opinion 11:366-373, 1989
 
9) 上野良三, 島津晃, 鳴島眞人, ほか:変形性膝関節症に対するアルテバロンの関節内注入療法の効果と安全性. 薬理と治療9:4321-4333, 1981
 
10) NRD101 製品説明書日本ルセル株式会社, 電気化学工業株式会社, 中外製薬株式会社, 1993
 
11) Rejhole V:Long term studies of anti-osteoarthritic drugs:an assessment. Semin Arthritis Rheum 17 (Suppl 11):35-53, 1987
 
12) Creamer P, Dieppe PA:Novel drug treatment strategies for osteoarthritis. J Rheumatol 20:1461-1463, 1993
PubMed
13) MclLwain H, Silverfield JC, Don TF, et al:intra-articular orgotein in osteoarthritis of the knee:a placebo-controlled efficacy, safety and dosage comparison. Amer J Med 87:295-300, 1989
 
P.292 掲載の参考文献
1) Rosenberg SA, Aebersold P, Cornetta K, et al:Gene transfer into humans:immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. N Engl JMed 323:570-578, 1990
 
2) Anderson WF:Human gene therapy. Science 256:808-813, 1992
PubMed
3) 遺伝子治療研究に関するガイドラインについて. 厚生科学会議 (1993年4月)
 
4) Mulligan RC:The basic science of gene therapy. Science 260:926-932, 1993
PubMed
5) 小谷 均, McGarrity GL:レトロウイルスベクターによる遺伝子治療. 実験医学 12:308-315, 1994
 
6) Kato K, Nakanishi M, Kaneda Y, et al:Expression of hepatitis B virus surface antigen in adult rat liver:co-introduction of DNA and nuclear protein by a simplified liposome method. J Biol Chem 266:3361-3364, 1991
 
7) Bandara G, Robbins PD, Georgescu HI, et al:Gene transfer to synoviocytes:prospects for gene treatment of arthritis. DNA and Cell Biol 11:227-231, 1992
PubMed
8) Bandara G, Mueller GM, Galea-Lauri J, et al:Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer. Proc Natl Acad Sci USA 90:10764-10768, 1993
PubMed
9) Roessler BJ, Allen ED, Wilson JM, et al:Adenoviral-mediated gene transfer to rabbit synovium in vivo. J Clin Invest 92:1085-1092, 1993
PubMed

手術

P.305 掲載の参考文献
1) Fornasier VL, Cameron HV:The femoral stem-cement interface in total hip replacement. Clin Orthop 116:248-252, 1976
 
2) Anthony PP, Gie GA, Howie CR, et al:Localised bone lysis in relation to the femoral components of cemented total hip arthroplasties. J BoneJoint Surg 72-B:971, 1990
 
3) Heilmann K, Diezel PB, Brinkmann KA:Morphologicall studies in tissue surrounding alloarthroplastic joints. Virchows Arch Path Anat 366:93-106, 1975
 
4) Goldring SR, Schiller AL, Roelke M, et al:The synovial-like membraneat the bone-cement interface in loose total hip replacements and its proposal role in bone lysis. J Bone Joint Surg 65-A:575-584, 1983
 
5) Murray DW, Rushton N:Macrophages stimulate bone resorpion when theyphagocytose particles. J Bone Joint Surg 72-B:988-992, 1990
 
6) Quinn J, Joyner C, Triffitt JT, et al:Polymethylmethacrylate-induced inflammatory macrophages resorb bone. J Bone Joint Surg 74-B:652-658, 1992
 
7) Poss R, Maloney JP, Ewald FC, et al:Six to eleven year reults of total hip arthroplasty in rheumatoid arthritis. Clin Orthop 182:109-116, 1984
 
8) Nixon JE:Failure patterns after total hip replacement. Br Med J 286:166-170, 1983
 
9) Eftekhar NS, Tzitzikalakis GI:Failures and re-operations following low friction arthroplasty of the hip. Clin Orthop 211:65-78, 1986
 
10) Inoue K, Nishioka J, Hukuda S, et al:Rheumatoid nodules at the cement-bone interface in revision arthroplasty of rheumatoid patients. J Bone Joint Surg 75-B:455-458, 1993
 
P.313 掲載の参考文献
1) 全国骨腫瘍患者登録一覧表 日本整形外科学会骨軟部腫瘍委員会発行 毎年
 
2) Uchida A, Hamada H, Yoshikawa H, et al:Surgical treatment of bone tumors arising from pelvic ring, In New Development for Limb Salvage in Musculoskeletal Tumors (Ed, Yamamura T), pp.451-458, Springer-Verlag 1989
 
3) Hurh JF, Bawson EG, Eilber FR:Abdominal resection for malignant tumors of the sacrum. Am J Surg 148:157-161, 1984
 
4) Austin-Seymour M, Munzenrider J, Goiten M, Verhey L, et al:Fractionated proton radiation therapy of chor doma and low-grade chondrosarcoma of the basa of the skull. J Neurosurg 75-A:1457-1465, 1993
 
6) 内田淳正, 名井陽, 荒木信人, ほか:小児悪性骨腫瘍の化学療法. 整形災害外科 37:135-142, 1994
 
7) Rosen G, Nirenberg A:Neoadjuvant chemotherapy for ostengenic sarcoma:afive year follow-up (T-10) and preliminary report of new studies (T-12). In Primary Chemotherapy in Cancer Medicine (Ed, Wagner T), pp.39-51, New York, Alan R Liss, 1985
 
8) Rosen G:Role of chemotherapy in the management of malignant bone tumors. In;Chinical Trends Orthopaedics (Ed, Stand LR), pp.152, New York, Thieme-Stratton, 1982
 
9) Enneking WF, Spanier SS, Gookmann MA:A system for surgical staging of musculoskeletal sarcoma. Clin Orthop 153:106-120, 1980
 
10) 富田勝郎, 川原範夫:脊椎 (原発性, 転移性) 腫瘍に対する脊椎全摘出術 (total en bloc spondylectomy). 臨床整形外科28:561-569, 1993
 
11) Ono K, Yonenobu K, Ebara S, et al:Prosthetic replacement surgery for cervical spine metastasis. Spine 13:817-822, 1988
PubMed
12) 米延策雄, 小野啓郎:脊椎癌転移に対する手術療法. 骨関節靭帯 541-549, 1989
 

書評

最近チェックした商品履歴

Loading...